Visit our Location
11860 Vista Del Sol Dr Suite 105,
El Paso, TX 79936
Give us a Call
+1 (915) 412-6680
Send us a Message
[email protected]
Opening Hours
Mon-Thu: 7 AM - 7 PM
Fri - Sun: Closed

Tag: functional medicine

ChiroMedBlogfunctional medicine

Orthobiologic Insights for Patients and Musculoskeletal Health

Delve into the science of musculoskeletal health and orthobiologic methods to boost recovery and maintain joint well-being.

Abstract

Welcome. I’m Dr. Alex Jimenez, and I am excited to share my perspective on a transformative shift happening in musculoskeletal (MSK) medicine. This educational post, from my viewpoint as a Doctor of Chiropractic and a Family Nurse Practitioner, explores the move from volume-driven to precision-based care in orthobiologics and regenerative medicine. For too long, physicians have been constrained by outdated systems, and patients have been offered limited solutions. This post is for my colleagues in the medical field and for patients seeking a deeper understanding of their health. We will journey through the latest evidence-based findings in orthobiologics, exploring why this field, despite its compelling science, has faced challenges in execution. I will outline a comprehensive framework—the Joint Vitality System—that I have developed to ensure consistent, superior outcomes. This system emphasizes precision diagnosis, biologic matching, and a structured, guided recovery plan.

We will delve into the physiological underpinnings of orthobiologics such as Platelet-Rich Plasma (PRP), contrast them with traditional treatments, and highlight the importance of an integrative model that combines chiropractic care, functional medicine, and medical oversight. The discussion will also cover the critical role of data collection, the importance of understanding the physiological drivers of disease—whether inflammatory, degenerative, or structural—and how our integrative approach at Injury Medical Clinic PA serves as a model for this new paradigm of care. Finally, I will explain how our multidisciplinary team, under the medical direction of Dr. Maria Guadalupe Cardenas, MD, provides a comprehensive framework for restoring function and delivering the transformative, whole-person health outcomes our patients deserve. My goal is to empower you with the knowledge to build or seek a practice that is not only sustainable and independent but also delivers the highest standard of patient-centered, regenerative care.

Our Collaborative and Integrative Approach in El Paso, TX

At Injury Medical Clinic PA (also known as Mission Plaza Injury Medical Clinic) in El Paso, Texas, our model is built on a multidisciplinary, patient-centered foundation. I am Dr. Alex Jimenez, and I am honored to work alongside our Medical Director and Collaborative Physician, Dr. Maria Guadalupe Cardenas, MD. Dr. Cardenas is Board Certified in Internal Medicine (NPI #1164426749, Texas MD License #J2933) and brings over 40 years of invaluable experience as our Medical Director and Collaborative Physician. This collaboration between a DC/APRN and an MD is a powerful synergy and is common in modern integrative and injury clinics.

This setup allows us to merge the distinct strengths of different medical disciplines to provide truly holistic patient solutions.

  • Dr. Cardenas (MD, Internal Medicine): Dr. Cardenas provides essential medical oversight, manages complex internal medicine conditions that impact musculoskeletal health, and ensures our protocols meet the highest standards of medical safety and efficacy. Her deep knowledge of systemic disease is critical when evaluating a patient’s candidacy for regenerative procedures, managing lab results, and ensuring our treatments are medically sound.
  • Dr. Jimenez (DC, APRN, FNP-BC, CFMP, IFMCP, ATN, CCST): As a Doctor of Chiropractic and a Board-Certified Family Nurse Practitioner with extensive certifications in functional medicine, I focus on the biomechanical, musculoskeletal, and functional aspects of health. My role involves using integrative chiropractic care to address spinal alignment, nervous system function, and structural integrity. As a nurse practitioner and functional medicine expert, I investigate the underlying physiological imbalances—in nutrition, hormones, and inflammation—that contribute to injury and disease.

Together, our team seamlessly integrates chiropractic adjustments, functional medicine diagnostics, medical management, rehabilitation, personal injury care, and orthobiologic therapies into a single, cohesive care plan. This allows us to address the patient as a whole person, not just an injured joint. For instance, before a regenerative procedure, we might use chiropractic care to ensure proper joint mechanics, functional medicine to optimize nutrient levels and reduce systemic inflammation, and medical oversight from Dr. Cardenas to manage a patient’s previously undiagnosed pre-diabetes—all of which are crucial for a successful outcome.

Rethinking the Business of Medicine: From Fear to Freedom

Many of us in the medical field come from the “School of Hard Knocks” when it comes to business. We’re trained to believe that if we don’t know every single detail about a subject, we shouldn’t even start. This mindset is rooted in our primary directive: “first, do no harm.” We fear that an error in judgment could have devastating consequences for a patient. However, I want to offer a different perspective: business is not as hard as medicine. The risks are fundamentally different.

  • What’s the worst that can happen in a small business venture? You don’t charge as much as you could have. You lose a little money one month, which you can make up the next. You buy ten units of a product instead of twenty to save on upfront costs, even if the per-unit price is slightly higher.
  • Were these devastating choices? Did anyone get harmed? Perhaps your bank account was temporarily a few dollars lighter, but that’s just the price of doing business and learning.

Most entrepreneurs “build the airplane while they’re flying it.” They just get started and figure things out along the way. As clinicians, we are incredibly smart and adept at learning. My own journey into private practice started with a copy of Medical Practices for Dummies. It got me surprisingly far! I missed a step about getting a business license right away, but it was easily corrected. No harm, no foul. The point is, it can all be figured out.

The Orthomolecular Micro-Practice: Precision Over Volume

The model I champion is what I call the orthomolecular micro-practice. This is not a volume-driven enterprise; it is a precision practice. In the traditional insurance-based world, the only way to increase revenue is to see more patients because the price per visit is fixed and often low. This leads to burnout, rushed appointments, and mountains of paperwork.

Consider this brutal statistic we’ve observed: the ratio is approximately 15:1. To earn the same revenue from a single orthobiologic cash-based procedure, I would need to see 15 insurance-based patients. If I see 30 patients in a day under the insurance model, I make the same amount as seeing just two or three orthobiologic patients. Think of the administrative burden: would you rather write 30 clinical notes or just two? The answer is obvious.

This is where technology like an AI scribe becomes a game-changer. I personally use a system (DeepScribe) that requires no clicks from me. I record my patient interactions, and by the time I leave the room, the note is fully and directly imported into my EMR. It saves an incredible amount of non-compensated time and allows me to be fully present with my patients.

The Precision Practice is built on a few core principles:

  • Precision over Volume: Focusing on a smaller number of patients allows for deeper, more comprehensive care.
  • Systems-Driven Approach: Every patient touchpoint, from the initial phone call to the follow-up, is standardized. This ensures a predictable, high-quality experience and makes the practice scalable without sacrificing consistency.
  • The Right Patients: We focus on attracting patients who are actively seeking the transformative solutions we offer. We don’t convince or use high-pressure sales tactics. We educate, present the expected outcomes, and empower them to make an informed decision.

Seeing just five to ten of these ideal patients a month can build a thriving, sustainable practice. Ten patients a month at an average of 50,000 in cash revenue. That’s a legitimate business that can cover payroll, rent, and more—all while seeing only ten patients a month.

Patient-Centered Outcomes Over Procedures: Why Value Is About Transformation

As a clinician, I have learned that patients do not come to us for injections—they come for transformation. They want their lives back: to lift grandchildren, to play pickleball, to work without pain, to sleep through the night, and to feel strong and capable again. This distinction guides everything we do.

  • Patients are not purchasing a syringe; they are investing in a meaningful outcome.
  • When care results in real, measurable functional restoration, it justifies expert-level compensation because it delivers lasting value.
  • The ethical compass remains true when we provide evidence-based methods, conduct meticulous data collection, and set transparent expectations for recovery.

In our clinic’s integrative system, we package what matters: a pathway that blends orthopedic and nervous system restoration, lifestyle changes, and structured rehabilitation. The end goal is simple: unlock the patient’s innate capacity for repair, and then guide it with science-backed steps.

Unlocking Pain Relief: How We Assess Motion to Alleviate Pain- Video

The Challenge of Execution in Orthobiologics

On May 2, 2026, I reflected on the state of orthobiologics, and it became clearer than ever that the science is not the issue. The research supporting the use of biologics such as Platelet-Rich Plasma (PRP) and Bone Marrow Concentrate (BMC) is compelling and continues to grow daily. We have evidence showing we can modify the inflammatory environment of a joint and even stimulate the replication of tenocytes (tendon cells).

So why isn’t this the first-line treatment for every appropriate MSK condition? The answer lies in execution. We’ve seen significant problems that have eroded patient trust and caused physician hesitation:

  • Inconsistent Outcomes: Clinic A’s PRP protocol differs markedly from Clinic B’s. This lack of standardization leads to unpredictable results.
  • Poor Patient Selection: A common pitfall is offering a single therapy for every condition. PRP is fantastic for many tendon-based issues, but it won’t cure severe, bone-on-bone hip arthritis with significant bone marrow edema. Using the wrong tool for the job is a recipe for failure.
  • Overpromising in Marketing: We’ve all seen the “stem cell” clinics that make miraculous claims without proper diagnostics or patient evaluation. This “Wild West” atmosphere, particularly prevalent in places like Florida, erodes public trust. The key is to under-promise and over-deliver.
  • Lack of Standardization and Measurement: As a field, we must be rigorous. Leading researchers have shown that a platelet dose above 5.5 billion is associated with more beneficial outcomes (Everhart et al., 2019). Are we measuring the platelet concentration in every PRP sample we prepare? We should be. If you can’t measure, you should at least know your system’s validated output. For instance, in our clinical observations, using a specific 60 cc draw with the Apex kit consistently yields approximately 10.8 billion platelets. This knowledge allows us to ensure we are delivering a therapeutic dose every single time.

These execution failures drive patients away from a field with immense potential and cause good physicians to second-guess their approaches. To ensure consistency and scalability, I developed the Joint Vitality System. This is not just a procedure; it is a comprehensive framework that guides our entire process, from initial consultation to full recovery.

The Joint Vitality System Part 1: Precision Diagnosis Beyond the Obvious

A successful outcome starts with an accurate and precise diagnosis. We cannot afford to guess. This requires a multifaceted approach:

  • Thorough History and Physical Exam: We must listen to our patients and touch our patients. You can have two patients with identical MRI reports but completely different sources of pain. One might have true intra-articular knee pain from synovitis, while the other’s “knee pain” is actually referred pain from an L4 radiculopathy or hip arthritis.
  • Diagnostic Musculoskeletal Ultrasound: This is not optional. It is a vital point-of-care tool that allows us to visualize tissues in real time, assess for inflammation, and pinpoint the exact source of pain. I can move the joint and ask, “Does it hurt right here?” while visualizing the underlying anatomy.
  • Reviewing Your Own Imaging: While radiologists’ reports are important, MSK-trained clinicians often see subtleties that general radiologists may miss. They might not comment on a high-intensity zone in a disc, a low-grade partial tendon tear, or a meniscocapsular junction sprain—all of which are significant pain generators that we can treat with orthobiologics.
  • Diagnostic Injections: I am a firm believer in the “show me” principle. If I am not 100% certain of the pain generator, I use diagnostic injections (e.g., with a local anesthetic) to confirm the source. This is a powerful tool. If numbing a specific structure provides significant temporary relief, we have confirmed our target. It’s a “try it before you buy it” approach for orthobiologics that gives both the patient and me confidence in the treatment plan.

We must differentiate between an inflammatory driver, a degenerative driver, and a structural driver. For example, a hot, swollen knee might be driven by inflammation (synovitis). In contrast, a chronically achy, mechanically unstable knee might be driven by degeneration (arthritis) or a structural problem (e.g., a meniscus tear). Each requires a different approach.

The Joint Vitality System Part 2: Biologic Matching for the Right Job

Once we have a precision diagnosis, we must match it with the appropriate biologic therapy. It is not a one-size-fits-all solution. The key question is: What does this specific tissue need to achieve our therapeutic goal?

  • Inflammation Control: If the primary problem is inflammation, our goal is immunomodulation. We need to flip pro-inflammatory M1 macrophages to an anti-inflammatory M2 phenotype. When this occurs in the knee synovium, something remarkable happens: the synovium begins to produce its own endogenous hyaluronic acid (Morigi et al., 2020). We can stimulate the body to heal itself.
  • Cellular and Growth Factor Support: For degenerative conditions like tendinopathy or mild-to-moderate arthritis, PRP is an excellent choice. It delivers a high concentration of growth factors that signal tissue repair and reduce inflammation. We tailor the leukocyte profile, using leukocyte-rich PRP for ligament/tendon issues and leukocyte-poor PRP for intra-articular arthritis to better modulate local inflammation (Dohan Ehrenfest et al., 2009).
  • Structural Scaffolding and Cellular Regeneration: For more significant issues, like a partial tendon tear with a visible gap or more advanced arthritis, we need more. Adipose tissue provides a structural scaffold (the extracellular matrix) and a rich source of mesenchymal stem cells (MSCs) and other regenerative cells. If there is a gap in a tendon that needs bridging, adipose is a superb option.
  • Bone and Cartilage Healing: For severe arthritis with associated bone marrow edema (a sign of stress and inflammation within the bone itself), Bone Marrow Concentrate (BMC) is often the superior choice. BMC contains MSCs and other progenitor cells that are crucial for bone and cartilage health. It is also a flowable product that can be injected intraosseously (directly into the bone) to treat bone marrow lesions, a capability not available with thicker adipose grafts.

We must also consider the delivery method. Putting an adipose graft (which requires an 18-gauge needle) into an intervertebral disc is not a sound application. The biologic must be appropriate for the tissue, the pathology, and the delivery method.

The Joint Vitality System Part 3: Structured Care and Guided Recovery

The procedure is just one part of the journey. A structured care plan is essential for guiding the patient and managing their expectations from start to finish. This includes a comprehensive rehabilitation program that turns improved biology into durable function. We use staged, criterion-based protocols:

  • Early phase (days 1–14): Protect the site, restore pain-free range of motion, gentle isometrics, and controlled closed-chain loading to stimulate mechanotransduction without overstrain.
  • Mid phase (weeks 3–8): Progressive resistance, eccentric training for tendons, neuromuscular control (balance, perturbation training), and pattern correction (hip hinge, scapular setting).
  • Late phase (weeks 9–16): Power development, return-to-sport drills, and task-specific conditioning (e.g., pickleball pivot work, lifting technique for grandparents).

If we perform a procedure on a tendon, the patient must follow a progressive tendon-loading program. This is non-negotiable. The mechanical signals from proper physical therapy are essential for guiding the new tissue as it remodels and strengthens. This is known as mechanotransduction, where cells sense load and trigger gene expression for collagen synthesis and alignment (Wang et al., 2012). Eccentric loading, in particular, promotes tendon remodeling.

Why We Start 30 Days Before the Procedure: Health Optimization and Risk Reduction

True recovery begins before the day of the procedure. Our pre-procedure window—often 30 days—allows us to “stack the deck” for repair. This whole-person approach is critical because healing is metabolically expensive.

Key optimization targets:

  • Hematologic readiness: We review complete blood count and iron studies. Adequate oxygen-carrying capacity is vital for cellular respiration and ATP production during healing (Stoltzfus et al., 2019).
  • Endocrine balance: We test thyroid function and sex hormones, such as estrogen and testosterone. We now know there are estrogen receptors in the knee, and estrogen has a protective effect on cartilage. Its decline during menopause is linked to an earlier onset of arthritis in women—sometimes 20 years sooner than in men (Sniekers et al., 2008). Optimizing hormones when clinically indicated supports collagen synthesis, bone density, and muscle integrity (Khosla & Monroe, 2018).
  • Nutritional status: We test for Vitamin D and other key nutrients. Ensuring adequate intake of vitamin D, omega-3 fatty acids, magnesium, and protein supports immune modulation and connective tissue repair (Calder, 2017; DiNicolantonio et al., 2018).
  • Glycemic control: An elevated Hemoglobin A1C indicates poor blood sugar control, which severely impairs healing. Lowering HbA1c improves microvascular function, reduces glycation end products, and enhances wound-healing quality (Singh et al., 2020).
  • Sleep and circadian alignment: Consistent sleep boosts growth hormone pulses and tissue repair, while circadian regularity improves insulin sensitivity and inflammatory tone (Luyster et al., 2012).

The Role of Integrative Chiropractic Neuromechanics in Recovery

Integrative chiropractic care is foundational for translating biological repair into functional performance. It is a key component of our guided recovery, helping prevent the recurrence of underlying mechanical stresses that may have caused the problem in the first place.

The physiology behind this approach is powerful:

  • Joint alignment and segmental mobility restore optimal arthrokinematics, reducing shear stress on healing tissues.
  • Proprioceptive enhancement recalibrates spinal and peripheral reflex loops, improving muscle firing patterns and reducing compensatory overuse. Pain alters motor control via central sensitization. Chiropractic adjustments help normalize afferent input to the nervous system, reducing hypervigilant reflexes.
  • Fascial release and myofascial remodeling improve glide planes, reducing nociceptive input and allowing normalized movement arcs.
  • Improved joint centration and balanced muscle co-contraction decrease joint microinstability, protecting healing cartilage and tendons from irregular load vectors.

My clinical observations confirm that pairing PRP with chiropractic-guided kinetic chain correction leads to faster time-to-function milestones and fewer relapses, especially in shoulder, knee, and lumbar dysfunctions (Jimenez, n.d.-a; Jimenez, n.d.-b). It ensures the body is optimally aligned to heal.

The Power of Relationships and Your Existing Patient Base

So, how do you find these patients? The growth of a successful orthobiologics practice comes from relationships. The two most powerful and durable sources of growth are:

  1. Clinician Referrals: Building a referral-based practice is the most sustainable model. We position ourselves as problem-solvers for our colleagues. An orthopedic surgeon sees many patients with non-surgical conditions, such as greater trochanteric bursitis (lateral hip pain). These cases rarely proceed to surgery and can be frustrating for a surgeon to manage. For us, it’s a perfect opportunity to apply orthobiologics.
  2. Your Existing Patient List: Your most valuable asset is the group of patients who already know, like, and trust you. The cost to reach a patient who is already in your system is zero. They haven’t heard from you about these new treatments because you haven’t offered them yet!

Let me share an example. I used to perform a lot of hyaluronic acid (HA), or “gel,” injections for knee arthritis. When I decided to stop, I contacted all my HA patients and explained that based on the latest evidence, PRP offered a superior outcome. I gave them the choice: transition to PRP with me or receive a referral for HA. The result? Thirty percent of my HA patients transitioned to orthobiologic care. The research supports this move. Studies, such as the one by Meheux et al. (2016), consistently show that PRP outperforms HA at every time point in treating knee osteoarthritis. When we educate patients, many will opt for the better outcome.

Data Collection: The DNA of Continuous Improvement

We collect data because better measurement produces better outcomes. If you are not collecting data on your patients, you are flying blind. I strongly advocate for using a registry like DataBiologics, founded by physicians for physicians. It provides an IRB-approved platform to track outcomes, allowing us to publish our data and, most importantly, tell our patients with confidence what they can expect from our specific treatments in our clinic.

What we track:

  • Pain scores (NRS/VAS), function scales (e.g., DASH, LEFS, Oswestry Disability Index), and patient-reported improvements.
  • Baseline and follow-up metrics for strength, mobility, and balance.
  • Adherence markers for nutrition, sleep, and activity.

A nominal $25 data fee added to the care package can cover system costs and foster engagement. This is how we move from anecdote to evidence. This is how we build trust.

Conclusion: A Modern, Evidence-Based Pathway to Recovery

The train of regenerative medicine is leaving the station. Our integrative framework, guided by medical oversight from Dr. Maria Guadalupe Cardenas, MD, and chiropractic leadership from me, delivers a measured, ethical, and effective route to patient transformation. We start early, combine biologic precision with biomechanical intelligence, optimize metabolism, and move patients through staged rehabilitation. We measure relentlessly, learn constantly, and stay aligned as a team. By embracing a systematic, evidence-based, whole-person approach, we can provide our patients with the exceptional care they deserve while building practices that are professionally and financially rewarding. This is how we practice medicine on our own terms, driven by science and a genuine desire to help our patients heal.

References

SEO Tags: orthobiologics, regenerative medicine, chiropractic care, integrative medicine, integrative chiropractic, Dr. Alex Jimenez, Dr. Maria Cardenas, El Paso TX, Platelet-Rich Plasma, PRP, PRP knee osteoarthritis, Bone Marrow Concentrate, BMC, musculoskeletal health, functional medicine, precision diagnosis, Joint Vitality System, stem cell therapy, sustainable medical practice, patient-centered care, evidence-based medicine, ultrasound-guided injections, tendon loading, hormone therapy, menopause and joint pain, guided rehabilitation, El Paso chiropractor, internal medicine medical director, weight loss arthritis, data collection outcomes, mechanotransduction, collagen synthesis, bone marrow aspirate concentrate, multidisciplinary injury clinic, Mission Plaza Injury Medical Clinic, Injury Medical Clinic, Precision Medicine, Knee Pain, Arthritis Treatment, Business of Medicine, Systems-Driven Practice, Whole Person Health

Chiropractic & Laser Therapy for Spine & Joint Pain Relief

Chiropractic & Laser Therapy for Spine & Joint Pain Relief

Chiropractic & Laser Therapy for Spine & Joint Pain Relief

Abstract

In this comprehensive educational post, I present a clear, step-by-step overview of how modern, robot-assisted and handheld multimode laser therapy fits within an integrative chiropractic and functional medicine framework for spine and joint pain. I explain patient positioning, energy-density dosing, safety considerations, and the clinical reasoning behind acute and chronic treatment protocols. I also discuss how our multidisciplinary team at Injury Medical Clinic PA (Mission Plaza Injury Medical Clinic) in El Paso, Texas integrates chiropractic care, internal medicine oversight, functional medicine, personal injury rehabilitation, and orthobiologics such as PRP. With medical direction from Dr. Maria Guadalupe Cardenas, MD (Board Certified in Internal Medicine; NPI #1164426749; Texas MD License #J2933) and collaborative protocols, we optimize outcomes using evidence-based methods, laser physics principles, mitochondrial support, and targeted rehabilitation pathways. Finally, I address practical questions about fracture timing, device durability, PRP timing, and how dose calibration by area improves care. This post summarizes current findings from leading researchers and reflects my clinical observations and protocols implemented in our clinic in alignment with modern literature.

Introduction: How Integrative Chiropractic Care and Internal Medicine Oversight Elevate Laser Therapy

I am Dr. Alexander Jimenez, DC, APRN, FNP-BC, CFMP, IFMCP, ATN, CCST. In our clinic, Injury Medical Clinic PA (also known as Mission Plaza Injury Medical Clinic) in El Paso, Texas, we embrace a multidisciplinary care model that blends chiropractic biomechanical correction with medical oversight, functional medicine, rehabilitation, and orthobiologics. Our Medical Director and Collaborative Physician, Dr. Maria Guadalupe Cardenas, MD, Board Certified in Internal Medicine (NPI #1164426749, Texas MD License #J2933), brings over 40 years of internal medicine experience to ensure safety, proper diagnosis, and evidence-based clinical governance.

  • The collaborative design:
    • Chiropractic care (Dr. Jimenez): biomechanical assessment, spinal and extremity adjustments, neuromuscular re-education, and movement-based rehabilitation.
    • Internal medicine oversight (Dr. Cardenas): diagnostic rigor, medication reconciliation, comorbidity management (e.g., diabetes, dyslipidemia, autoimmune disease), and risk mitigation.
    • Functional medicine: root-cause analysis, nutritional optimization, mitochondrial support, inflammation modulation, and gut-musculoskeletal axis considerations.
    • Personal injury and rehabilitation: staged care, objective outcome measures, return-to-function protocols.
    • Advanced modalities: multimode laser therapy (robotic and handheld), shockwave where appropriate, and adjunct orthobiologics (e.g., PRP) under medical guidance.

This integrated paradigm ensures that when we use laser therapy, we do so with precise dosing, physiological intent, and clear safety thresholds—all aligned with modern research and clinical practice guidelines.

Laser Therapy Fundamentals: Patient Comfort, Precision, and Protocols

When I deploy laser therapy in the clinic, I prioritize one principle above all: patient comfort and positional stability. If a robotic platform is used, the patient must be positioned to minimize movement to preserve targeting accuracy and energy-density delivery.

  • Positioning and contact:
    • Low back: face-down positioning enables direct skin contact, stable landmarks, and clear indexing over regions such as L4-L5 facets.
    • Handpiece contact vs. robotic distance: the handheld diode often requires direct skin contact for precise focal delivery, whereas the robot can be placed at a calibrated distance (e.g., approximately 6 inches) with a standardized ruler to maintain the proper focal plane.
  • Targeting workflow:
    • Identify primary symptom locus (e.g., right-sided facet-related stiffness or referred pain).
    • Zero the X and Y axes to center the robot’s field over the target.
    • Expand the X and Y to cover both the symptomatic region and adjacent connective tissues.
    • Use a clinical multimodal approach that treats the site of pain, the likely source, and surrounding fascial/intersegmental tissues.
  • Why comfort and stability matter:
    • Precision delivery of a prescribed energy density requires that the patient remain still; otherwise, the laser’s calibrated footprint won’t match the intended anatomical target.
    • Consistency in delivery improves reproducibility and patient outcomes while minimizing the risk of dosage variability.

The Science of Energy Density: Why Joules per Centimeter Squared Matters

Laser therapy dosing is best conceptualized in terms of energy density, measured in joules per square centimeter (J/cm²), rather than total joules. Modern literature and clinical consensus point to dosing windows, often in the range of 4–10 J/cm², for many musculoskeletal applications.

  • Key concept: energy density is the dose, not simply total energy. It accounts for the area treated, helping us avoid over- or under-delivery.
  • Typical dosing range: approximately 4–10 J/cm² for pain and inflammation modulation, with calibration adjusted to condition severity and tissue depth (World Association for Laser Therapy guidance and aligned literature).
  • Software calibration advantage: when we adjust the X-Y area, advanced systems automatically recalibrate treatment time to maintain the set J/cm². This prevents manual calculation errors and ensures consistent dosing across varied anatomical footprints.
  • Why not chase total joules alone? Focusing only on total joules can lead to treating either too large or too small an area without achieving the desired density. Energy density ensures that photonic energy per unit area reaches cellular targets at bioactive thresholds.

Pulse Technology, Thermal Behavior, and Safety

Modern high-peak-power lasers can deliver therapeutic energy without excessive surface heating by using very short pulse durations, paired wavelengths, and built-in rest periods for energy absorption.

  • Key technical points:
    • Peak power characteristics (e.g., 50 W pulse capability) allow deeper photon penetration within safe thermal limits when paired with proper wavelength selection.
    • Dual-wavelength strategies (e.g., 808 nm continuous or quasi-continuous and 905 nm pulsed) provide complementary tissue interactions. The pulsed approach reduces sustained thermal accumulation, allowing tissue absorption without overheating.
    • Thermal homeostasis: when tissue temperature remains stable over time, the device is delivering energy at the right pace and dose. Feeling surface heat during treatment often means wrong wavelengths, too much energy too fast, or insufficient pulsing.
    • Practical observation: patients may feel mild warmth or tingling; most do not experience significant sensations due to nanosecond pulse timing and photobiomodulation rather than thermal ablation.
  • Why pulse matters physiologically:
    • The mitochondrial electron transport chain (ETC) and chromophores (e.g., cytochrome c oxidase) respond to photons in specific wavelengths, increasing ATP production without requiring bulk heat.
    • Pulsing permits photon delivery that favors cellular signaling pathways (e.g., nitric oxide dissociation, improved microcirculation) while minimizing thermal overload.

Clinical Multimodal Strategy: Robot-Assisted and Handheld Synergy

Our protocols frequently use both robotic and handheld laser applications during the same session. The robot can deliver energy across a mapped region while the handheld tool targets trigger points, facet joints, or entheses with precision.

  • Synergistic workflow:
    • Robot: covers the broader symptomatic region with calibrated X-Y fields and appropriate energy density.
    • Handheld: addresses focal points such as knots (myofascial trigger points), joint spaces, and dynamic tissues during movement if needed.
    • Timing: handheld applications may be short (e.g., approximately 25 seconds per focal spot) and repeated across several points while the robot runs through a longer program (e.g., 6–12 minutes).
  • Why this pairing works:
    • Regional coverage addresses inflammatory mediators, edema, and fascial tightness.
    • Focal delivery modulates neuromuscular trigger points, reduces tone in hyperactive bands, and influences local perfusion.
    • Integrates well with chiropractic adjustments and rehab exercises to restore proper biomechanics, reduce pain, and improve tolerance to movement.

Acute vs. Chronic Protocols: Cumulative Effects and Scheduling

Laser therapy effects are cumulative. While some patients report improvement within hours, best outcomes arise from structured series.

  • Acute conditions:
    • Suggested initial series: approximately 6 treatments.
    • Frequency: at least 24 hours between sessions; practical cadence is often Monday-Wednesday-Friday.
    • Expected time course: noticeable improvements can occur after 1–3 treatments; reassess at 4–6 with functional tests.
  • Chronic conditions:
    • Suggested initial series: approximately 12 treatments.
    • Frequency: at least 24 hours between sessions; same practical three-per-week cadence.
    • Why complete the series: early improvement may tempt patients to stop prematurely. Completion ensures robust and durable changes in inflammatory signaling and mitochondrial dynamics.
  • Maintenance:
    • For degenerative or recurrent conditions (e.g., osteoarthritis, chronic tendinopathies), maintenance programs may be implemented after the initial series, tailored to flare patterns and functional goals.

Knee Osteoarthritis: Dosing, Positioning, and Patellar Considerations

For knee osteoarthritis, we consider joint geometry and energy reflection.

  • Positioning:
    • Avoid direct anterior-only shots on a fully extended knee due to patellar reflection.
    • Flexion can expose more joint surface area to effective photon delivery and reduce energy loss.
  • Compartment targeting:
    • Medial compartment disease is common; address medial, lateral, anterior (with flexion), and posterior approaches as needed.
    • Apply energy density per compartment rather than summing total joules across the knee. Calibrate each mapped area to its indicated J/cm² and allow software to adjust time automatically.
  • Outcomes:
    • Laser therapy can reduce pain and inflammation and improve function. It does not regenerate cartilage in bone-on-bone scenarios but frequently helps delay escalation to invasive intervention by improving symptom control and quality of life.

Fracture Considerations: Timing and Physiological Rationale

While soft tissue applications dominate the evidence base, clinicians have reported positive experiences with early laser use for fractures under certain conditions. We approach this area cautiously under the medical oversight of Dr. Cardenas.

  • Timing:
    • Anecdotally, early application within approximately 7–10 days may support the inflammatory phase, perfusion, and early healing signaling. This is approached on an off-label, case-by-case basis.
    • Non-union scenarios are complex and typically require broader interventions; laser may serve as an adjunct but not a standalone solution.
  • Rationale:
    • Early photobiomodulation may modulate inflammatory mediators, improve microcirculation, and influence osteoblastic activity through mitochondrial pathways, but evidence is heterogeneous and must be individualized under MD direction.

Orthobiologics Integration: Preparing the Soil for PRP and Beyond

Laser therapy and PRP can be paired strategically to optimize the injection environment, support post-injection recovery, and potentially improve outcomes.

  • Pre-injection priming:
    • Two to three laser sessions before PRP may enhance local perfusion, reduce maladaptive inflammation, and create a favorable milieu for cellular activity.
    • Day-of-injection: use settings that stabilize the local environment and support immediate post-procedural comfort.
  • Post-injection:
    • Approximately six sessions post-injection can support pain control, circulation, and mitochondrial activity during the early healing window without negating the desired pro-inflammatory cascade of PRP. Rather than suppressing inflammation, laser aims to modulate and guide it toward productive repair.
  • Protocols:
    • We use provider-driven, literature-informed protocols synchronized with orthobiologic timelines. Our internal medicine oversight ensures alignment with patient-specific comorbidities and medications.

Mitochondrial Optimization: From Photobiomodulation to Nutritional Support

Laser therapy enhances mitochondrial function through photobiomodulation—most notably by interacting with cytochrome c oxidase and modulating nitric oxide signaling. This translates into improved ATP generation, cellular resilience, and adaptive metabolism.

  • Mechanisms:
    • Photonic stimulation increases electron transport chain activity, ATP output, and reactive oxygen species signaling within physiological ranges that promote repair.
    • NO modulation can improve microvascular perfusion, reduce local hypoxia, and facilitate nutrient delivery.
  • Adjunct strategies (functional medicine):
    • When appropriate and safe, we consider mitochondrial support, including CoQ10, NAD+ precursors, creatine, and targeted micronutrients. We also address lifestyle factors (glycemic control, sleep, movement).
    • Pharmacologic interactions: statins and certain medications can negatively influence mitochondrial function. Dr. Cardenas oversees medication reconciliation and counsels patients on safe optimization strategies, ensuring contraindicated changes are avoided without medical approval.
  • Why this integrative approach works:
    • Combining photobiomodulation with metabolic support and biomechanical correction ensures that increased ATP production is matched by improved movement patterns and tissue loading. This reduces relapse and drives functional restoration.

Real-Time Dose Visualization and Practical Tips

Modern robotic systems allow visualization of the active treatment area. For example, a visible triangle may reflect the 808 nm component, while pulsed wavelengths (e.g., 905 nm) might not be captured by smartphone cameras due to pulse characteristics.

  • Practical pearls:
    • Use visual guides to confirm alignment with the symptomatic region.
    • Employ rulers and standardized spacing to maintain correct focal distances.
    • Communicate sensations: patients may feel mild warmth or tingling; reassure based on normal pulse technology effects and verify comfort throughout.

Avoiding Bioinhibition: The Arndt-Schulz Law and Distributed Coverage

Photobiomodulation follows dose-response principles. Too little energy yields no effect; too much can inhibit cellular function.

  • Strategy:
    • Stay within recommended energy density ranges.
    • If extending treatment time, distribute coverage rather than stacking excessive energy on a single point.
    • Consider anterior-posterior or medial-lateral mapping for joints to spread dose and maintain optimal cellular stimulation.

Device Reliability, Service, and Clinical Deployment

Clinics often ask about durability and support. Field-service models and on-site training help ensure consistent operation. Our protocols leverage both robot-assisted and handheld applications to deliver comprehensive care.

  • Reliability:
    • Robust installation and service support minimize downtime.
    • On-site maintenance reduces risks associated with shipping sensitive devices.
  • Training:
    • Structured onboarding allows staff to apply evidence-based protocols safely and consistently, freeing clinicians to focus on assessment, high-level planning, and patient counseling.

Integrating Chiropractic Care Within the Laser Framework

Chiropractic care is foundational to our musculoskeletal program. Laser therapy complements adjustments and rehabilitation by modulating pain, inflammation, and tissue readiness.

  • Chiropractic integration:
    • Adjustments restore segmental motion and reduce mechanical stress on involved joints and soft tissues.
    • Laser therapy calms nociceptive input, improves circulation, and enhances mitochondrial function—creating an environment where adjustments and exercises yield greater benefits.
    • Rehabilitation includes core stabilization, proprioception training, fascial mobility, and progressive loading tailored to the patient’s condition and response to laser and manual therapies.
  • Personal injury care:
    • Objective measures (pain scales, ROM tests, functional outcomes) track progress across laser sessions and chiropractic care stages.
    • MD oversight ensures that red flags (e.g., neurologic deficits, systemic issues) are addressed promptly.

Clinical Observations and Practice Insights

In my practice, I have observed that:

  • Patients with facet-mediated low back pain experience notable symptom relief when laser is combined with targeted adjustments and trunk stabilization. The early window of improvement often emerges 4–6 hours post-treatment and compounds over multiple sessions.
  • For knee osteoarthritis, flexed positioning and compartment-specific mapping improve comfort and functional outcomes, especially when combined with weight management, gait training, and anti-inflammatory nutrition.
  • Trigger point therapy using a handheld laser, followed by myofascial release and corrective exercises, accelerates pain reduction and increases carryover from chiropractic sessions.

Evidence-Based Context and Citations

Modern literature has clarified the importance of energy density and photobiomodulation parameters in musculoskeletal care. The World Association for Laser Therapy and multiple peer-reviewed studies support dosing in the 4–10 J/cm² range for many applications. Dual-wavelength pulse strategies and the Arndt-Schulz law inform our therapeutic windows, while clinical protocols integrate PRP timing to harness synergistic benefits rather than suppress important pro-inflammatory steps.

  • Energy density and dose-response:
    • Targeting J/cm² is more predictive of outcomes than chasing total joules alone (WALT guidance; see references).
    • Avoiding bioinhibition by staying within optimal ranges ensures cellular stimulation rather than suppression.
  • PRP integration:
    • Priming and post-injection laser protocols can improve patient comfort, functional recovery, and overall outcomes without negating PRP’s inflammatory phase. The art is in timing, settings, and patient-specific calibration, coordinated under MD oversight.

How We Operationalize Care in Our Clinic

  • Intake and diagnosis:
    • Comprehensive evaluation with imaging when indicated, medication review, and metabolic and inflammatory markers.
  • Plan formation:
    • Chiropractic adjustment plan, laser mapping, energy-density targets, rehab progression, and functional-medicine support.
  • Execution:
    • Robotic laser for regional coverage, handheld for focal points, three-per-week cadence for chronic care, reassessment at defined milestones.
  • Safety and quality:
    • Continuous monitoring, MD oversight for complex cases, patient reporting of sensations and functional tests, and tight dose control using automated area-time recalibration.

Why This Matters for Patients

Patients benefit from care that is comfortable, precise, and backed by research. Our integrated approach reduces pain without relying solely on medications, promotes natural tissue recovery, and aligns with personal injury recovery timelines and functional goals. While laser therapy is not a structural cure for severe degenerative changes (e.g., bone-on-bone), it can meaningfully improve quality of life, extend the window for conservative management, and enhance the benefits of chiropractic and rehabilitation.

Key Takeaways

  • Focus on energy density (J/cm²), not just total joules.
  • Use pulse technology to deliver high-peak power safely without overheating tissue.
  • Combine robotic regional coverage with handheld focal targeting for comprehensive care.
  • Follow a structured series: approximately 6 treatments for acute, 12 for chronic; effects are cumulative.
  • Integrate chiropractic, functional medicine, internal medicine oversight, and rehabilitation to maximize outcomes.
  • Pair laser with orthobiologics using evidence-informed timing to augment repair rather than suppress beneficial inflammation.
  • Maintain patient comfort and stability for accurate dosing and reproducible results.

References

  • World Association for Laser Therapy (WALT). (2010). Guidelines for Laser Therapy Dose Recommendations. https://waltza.co.za/documentation/guidelines
  • Hamblin, M. R. (2017). Mechanisms and applications of the anti-inflammatory effects of photobiomodulation. AIMS Biophysics, 4(3), 337–361. https://www.aimspress.com/article/doi/10.3934/biophy.2017.3.337
  • Chow, R. T., Johnson, M. I., Lopes-Martins, R. A. B., & Bjordal, J. M. (2009). Efficacy of low-level laser therapy in the management of neck pain: A systematic review and meta-analysis of randomized placebo or active-treatment controlled clinical trials. Lancet, 374(9705), 1897–1908. https://doi.org/10.1016/S0140-6736(09)61522-1
  • Bjordal, J. M., Couppe, C., Chow, R. T., Tuner, J., & Ljunggren, E. A. (2003). A systematic review of low-level laser therapy with location-specific doses for pain and disability in knee osteoarthritis. Photomedicine and Laser Surgery, 21(5), 241–245. https://doi.org/10.1089/pho.2003.21.241
  • Rojas, J. C., & Gonzalez-Lima, F. (2011). Low-level light therapy of the eye and brain. Eye and Brain, 3, 49–67. https://doi.org/10.2147/EB.S21390
  • Hashmi, J. T., Huang, Y.-Y., Sharma, S. K., Kurup, D. B., De Taboada, L., Carroll, J. D., & Hamblin, M. R. (2010). Effect of pulsing in low-level light therapy. Lasers in Surgery and Medicine, 42(6), 450–466. https://doi.org/10.1002/lsm.20954

Metabolic Health: A Comprehensive Guide to Understanding Obesity & Diabetes


Understand the effects of obesity and diabetes on overall wellness and take steps towards improvement in your metabolic health.

Abstract

Hello, I’m Dr. Alex Jimenez. In this educational post, we will embark on a comprehensive journey to understand the intricate and often overlapping physiological pathways of obesity, type 2 diabetes, and cardiovascular disease. I will present a patient-centered, first-person narrative describing how I approach these conditions through an integrative lens that blends chiropractic care, functional medicine, medical oversight, and rehabilitation. Drawing on the latest evidence-based research from leading experts, we will explore why treating obesity is not a matter of willpower but of addressing deep-seated biological dysregulation. We will delve into how inflammation, insulin resistance, and hormonal imbalances form a common pathological foundation for these chronic conditions. This discussion will highlight how modern pharmacotherapy targets these underlying mechanisms and why a chronic disease management model is essential for long-term success. Furthermore, I will explain how our unique multidisciplinary practice at Injury Medical Clinic PA integrates my chiropractic and functional medicine care with medical direction from our collaborative physician to provide a holistic and powerful treatment strategy for patients grappling with these complex cardiometabolic issues. We will break down the science, examine treatment guidelines, and illustrate how a synergistic approach, through real-world patient scenarios, can lead to profound improvements in health and quality of life.

Our Integrative Team: A Multidisciplinary Powerhouse

At Injury Medical Clinic PA, also known as Mission Plaza Injury Medical Clinic, in El Paso, Texas, our philosophy is rooted in collaboration and integration. We believe that the most effective patient care comes from combining the strengths of different medical disciplines. I am Dr. Alexander Jimenez, and my credentials as a Doctor of Chiropractic (DC), Advanced Practice Registered Nurse (APRN), board-certified Family Nurse Practitioner (FNP-BC), and advanced certifications in Functional Medicine (CFMP, IFMCP, ATN, CCST) allow me to view patient health through a multifaceted lens. My focus is on the structural, neurological, and functional aspects of wellness.

Functional Hormone, Thyroid, and Pellet Care Solutions

A cornerstone of our practice is our collaboration with Dr. Maria Guadalupe Cardenas, MD. Dr. Cardenas is Board Certified in Internal Medicine with an impressive 40 years of experience (NPI #1164426749, Texas MD License #J2933). She serves as our Medical Director and Collaborative Physician, providing invaluable medical oversight, ensuring our protocols are evidence-based, and offering a deep understanding of internal medicine. This partnership between a chiropractor and an internist allows us to create a truly comprehensive care model, which is a standard and effective setup in integrative and injury care clinics.

Our team works in synergy to address the full spectrum of a patient’s needs. Here’s how our services fit together:

  • Medical Oversight (Dr. Cardenas, MD): Dr. Cardenas guides our medical protocols, confirms diagnoses, manages complex internal medicine conditions, reviews contraindications, and provides the necessary supervision for prescription therapies and advanced medical interventions. Her extensive experience is crucial for diagnosing and treating systemic diseases that often accompany musculoskeletal issues, such as diabetes and cardiovascular disease.
  • Chiropractic & Functional Medicine (Dr. Jimenez, DC, APRN, FNP-BC): I focus on restoring the body’s natural function. Through chiropractic adjustments, we can improve nervous system function, reduce pain, and enhance mobility. This is particularly important for patients with obesity, as pain can be a major barrier to physical activity. Through functional medicine, we dive deep to identify the root causes of dysfunction—be it gut dysbiosis, hormonal imbalances, or nutrient deficiencies—and create personalized plans involving nutrition, supplementation, and lifestyle changes to restore health from the inside out.
  • Rehabilitation & Personal Injury Care: Our team also includes specialists in physical rehabilitation who help patients recover from injuries and improve their functional capacity. This is a critical component of managing obesity, as structured exercise programs are essential for building muscle, improving metabolism, and supporting weight loss.

By integrating these disciplines, we don’t just treat symptoms; we treat the whole person. We address the structural, biochemical, and medical aspects of health simultaneously, providing a level of care far more effective than any single approach could be.

Understanding the Roots of Cardiometabolic Disease

In my clinical practice, we frequently manage conditions like dyslipidemia (abnormal blood fats), hypertension (high blood pressure), and various metabolic disorders. For decades, we have had a wide array of medications to manage the symptoms of these diseases. However, a crucial understanding has emerged from modern research: in many cases, obesity is the underlying root cause of these interconnected health problems.

Imagine a tree. The branches and leaves—the visible parts—are the diseases we commonly treat, such as heart disease, diabetes, and high blood pressure. But the roots, hidden beneath the surface, represent the foundational issue of obesity. These are the obesity-related complications and comorbidities that drive the majority of chronic diseases we face today.

The Misconception of Willpower: Obesity Causes Overeating

The human body possesses remarkably resilient, tightly regulated systems. If you become dehydrated, your kidneys conserve water, and you feel thirsty, prompting you to drink. In the same way, body weight is meant to be tightly regulated. However, in obesity, this regulatory system becomes dysfunctional. A groundbreaking shift in our understanding is this: Overeating doesn’t cause obesity; obesity causes overeating. Before a noticeable increase in fat mass (adiposity) occurs, a dysregulation of the endocrine system is already underway.

  • The First Hit: Hormonal Dysregulation
  • The process begins when something—be it genetics, environmental factors, or obesogenic medications—triggers the “on” switch for obesity. Once activated, the body’s production of hunger hormones (like ghrelin) increases, while the production of satiety hormones (like leptin and GLP-1) decreases. This creates a powerful biological drive for increased hunger and food intake.
  • The Second Hit: The Brain Defends a Higher Weight
  • The second, and perhaps more insidious, part of this pathology is that the brain begins to defend this new, higher body weight as its “normal.” This is the biological reality behind the frustrating cycle of weight regain. We now know it’s a consequence of dysregulated biology. The leading hypothesis is that this defense mechanism arises from inflammation in the hypothalamus, the brain’s control center for appetite and energy expenditure.

Obesity is an incredibly multifactorial disease, influenced by over 200 genes, endocrine-disrupting chemicals, poor sleep, and chronic stress.

The Pathophysiological Overlap of Diabetes and Heart Disease

To truly appreciate the interconnected nature of these conditions, let’s look at the underlying biology of each.

The Progression of Type 2 Diabetes

The pathophysiology of type 2 diabetes unfolds over years, beginning with insulin resistance, where cells become less responsive to insulin. To compensate, the pancreatic beta cells work overtime, producing more insulin. Eventually, these cells become exhausted, leading to impaired insulin secretion and elevated blood sugar (hyperglycemia), a condition known as prediabetes. As function declines further, type 2 diabetes is diagnosed. Beyond the pancreas, diabetes involves chronic inflammation, gut dysbiosis, and mitochondrial dysfunction, which contribute to “metabolic memory,” perpetuating the disease.

The Inflammatory Core of Cardiovascular Disease

Cardiovascular disease shares a similar common denominator: atherosclerosis, the buildup of plaque in the arteries, which is fundamentally driven by inflammation. A key player is nitric oxide (NO), a critical molecule that promotes vasodilation (widening of blood vessels) and reduces inflammation. In cardiovascular disease, nitric oxide availability decreases, leading to increased blood clotting, rampant inflammation, and endothelial dysfunction (damage to blood vessel linings). Metabolically, this leads to decreased glucose tolerance, elevated triglycerides, and increased oxidative stress.

The Unifying Theory: Inflammation, Lipotoxicity, and Mitochondrial Dysfunction

A clear picture emerges when we put it all together. The journey often begins with obesity, which fosters chronic inflammation and lipotoxicity (cellular damage from excess fats). This environment leads to mitochondrial dysfunction, impairing cellular energy production. This trifecta—inflammation, lipotoxicity, and mitochondrial dysfunction—creates a vicious cycle, driving the progression of obesity, insulin resistance, type 2 diabetes, and ultimately, cardiovascular disease.

Patient Journey: Stephen’s Case and Early Intervention for Prediabetes

To illustrate these concepts, let’s look at a patient I’ll call Stephen. His journey highlights how we apply this integrative model in practice.

Case Introduction and Risk Profile

Stephen is a 24-year-old male who sees me for follow-up regarding prediabetes and weight management. His A1C is 5.8%. He has a history of progressive weight gain, reaching a current weight of 250 lb with a BMI of 32.1 (class I obesity). His family history is significant for obesity, cardiovascular disease, and type 2 diabetes. His exam reveals central adiposity with a waist circumference of 41 inches, acanthosis nigricans, and skin tags, all signs of chronic hyperinsulinemia and insulin resistance.

From a physiological standpoint, Stephen exhibits a classic metabolic phenotype driven by:

  • Visceral adiposity: Central fat secretes pro-inflammatory adipokines and reduces adiponectin, impairing insulin sensitivity.
  • Hepatic insulin resistance: Increased liver glucose production and dyslipidemia, increasing his risk of metabolic dysfunction-associated steatotic liver disease (MASLD).
  • Endocrine signals: Altered leptin signaling and dysregulated GLP-1/GIP pathways that reduce satiety.
  • Biomechanics: Excess abdominal load increases lumbar lordosis and knee strain, areas where chiropractic integrative care can provide structural relief.

Evidence-Based Weight Loss Targets: Why Percentages Matter

I explained to Stephen that targeted weight-loss thresholds can dramatically change his health trajectory:

  • 3% weight loss: Measurable improvements in prediabetes and insulin sensitivity.
  • 10% weight loss: Robust changes in glucose control, lipids, and blood pressure.
  • 15%+ weight loss: Meaningful impact on type 2 diabetes, dyslipidemia, hypertension, sleep apnea, and MASLD.

Reducing adipose tissue lowers inflammatory cytokines, restores hormonal balance, and improves insulin signaling. These targets guide our decision on whether to use lifestyle changes alone or incorporate anti-obesity pharmacotherapy.

Patient Journey: Victoria – The Intersection of Menopause, Weight Gain, and Diabetes

Now, let’s explore a case representative of what many women experience during menopause.

Initial Presentation and History

Victoria, a 52-year-old woman, came to my clinic for a follow-up on her prediabetes and recent weight gain. She had recently entered menopause and gained 15 pounds in the past year. Her job is largely sedentary, her activity level has decreased, and she suffers from poor sleep due to night sweats.

Key Clinical Details:

  • BMI: 31.8 (class 1 obesity)
  • Fat Distribution: Central adiposity, with a neck circumference of 16 inches, a risk factor for sleep apnea.
  • Symptoms: Hot flashes, snoring, and high stress.

The Menopausal Transition and Metabolic Disruption

Victoria’s case is a classic example of the metabolic storm that accompanies menopause. The decline in estradiol leads to a rise in LDL cholesterol, decreased insulin sensitivity, a shift toward increased body fat, and endothelial dysfunction. These changes amplify cardiovascular risk. Fortunately, menopause hormone therapy (MHT) can mitigate many of these risks.

Laboratory Findings and Diagnosis

Victoria’s lab work confirmed our concerns. Her HbA1c had risen to 7.3%, diagnosing her with type 2 diabetes. Her HOMA-IR score, a measure of insulin resistance, was 4.7, indicating significant dysfunction.

Crafting a Patient-Centered Treatment Plan

Using a shared decision-making model, I asked Victoria, “What area would you like to target first?” She chose to try a higher dose of metformin and was intrigued by the idea of using a Continuous Glucose Monitor (CGM). The CGM provides invaluable real-time feedback that drives positive behavior changes. We also referred her to a menopause specialist.

When Victoria returned, her CGM data was eye-opening. Her average glucose was 173 mg/dL, and she was spending 34% of her time in hyperglycemia. Armed with this new insight, she committed to increasing her metformin, boosting protein intake, and eliminating sugar-sweetened beverages. A month later, after starting MHT, her sleep and hot flashes improved, but her weight loss was slow. At this point, I introduced semaglutide, a GLP-1 receptor agonist. One year later, she had lost 25 pounds, her BMI dropped from 31.8 to 27.5, and her metabolic markers improved dramatically. By treating her obesity, we achieved remission of her diabetes.

Patient Journey: Banny – Addressing Long-Standing Diabetes and Cardiovascular Risk

Our next case involves Banny, a 64-year-old man with a long and complex medical history, including type 2 diabetes for 25 years, hypertension, and a previous heart attack. His weight was 230 lbs (BMI of 36), and he struggled with food cravings and uncontrolled blood pressure.

The “5 C’s” of Obesity Treatment

When evaluating Banny, I used my “5 C’s” framework: Criteria, Contraindications, Combine, Cues/Causes, and Cost/Coverage. His history of cardiovascular disease made him a prime candidate for a GLP-1 receptor agonist like semaglutide, which has been shown to reduce the risk of major adverse cardiovascular events. I framed it as a way to not only manage his diabetes and weight but also reduce his risk for a second heart attack. He was immediately on board.

Uncovering Hidden Liver Disease

Banny’s labs showed a slightly elevated liver enzyme (ALT), prompting me to calculate his FIB-4 score, a non-invasive screen for liver fibrosis. His score of 2.25 placed him at high risk. This is critical, as up to 65% of people with type 2 diabetes have Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD). I referred him to a gastroenterologist for further evaluation.

One year later, Banny had lost 23 pounds, and his HbA1c improved to 5.9%. He was diagnosed with liver fibrosis and started on a new medication. However, his weight loss had plateaued, and he struggled with intense food cravings. To address this, we added a low dose of topiramate at night to help control cravings, demonstrating a multi-pronged approach to modern obesity management.

Chiropractic Care & Metabolism *The Hidden Link*- Video

A Unified Approach to Treatment: Beyond “Eat Less, Move More”

The treatment guidelines for obesity, diabetes, and cardiovascular disease share a common foundation: a healthy eating plan, increased physical activity, and behavioral interventions. For diabetes and heart disease, we readily use medications, yet for obesity, there’s a misguided notion that patients must first “fail” lifestyle changes. This ignores the biological reality of the disease, where metabolic adaptation fiercely defends a higher body weight. Medications for obesity directly counteract the pathological hormonal and neurological changes driving the disease.

Nutrition Strategy: Creating Sustainable Metabolic Change

For patients like Stephen, we design a sustainable, enjoyable nutrition plan. This includes:

  • Caloric reduction: A deficit of 500- 750 kcal daily.
  • Carbohydrate management: Moderating refined carbs to improve insulin signaling.
  • Protein prioritization: To support satiety, thermogenesis, and muscle retention.
  • Fiber and non-starchy vegetables: To improve glycemic control and gut microbiome diversity.

Behavioral Health Strategy: Sleep, Stress, and Mood

Chronic stress and poor sleep worsen insulin resistance and weight gain by increasing cortisol and altering ghrelin and leptin levels. We screen for and address stress, mood, and sleep disorders, such as sleep apnea.

Physical Activity: Graded Movement and Functional Capacity

I provide evidence-based recommendations, such as 150-300 minutes/week of moderate-intensity activity and resistance training at least two days a week. For patients with pain, we incorporate referrals to physical and occupational therapy.

The Role of Modern Medications

The advent of GLP-1 receptor agonists (like liraglutide and semaglutide) and dual GIP/GLP-1 agonists (like tirzepatide) has been a game-changer. These medications mimic the body’s natural satiety hormones, helping patients achieve an average weight loss of 15-20% or more. Excitingly, many of these newer drugs, along with SGLT-2 inhibitors, have demonstrated significant cardiovascular benefits.

Recent multi-year research on tirzepatide has shown it can sustain a diabetes-free status in adults with prediabetes and deliver high-magnitude weight loss. For Stephen, after reviewing his options, we selected tirzepatide, starting at 2.5 mg weekly and titrating up. Two weeks later, he had lost 3 lbs. At one year, after reaching a 15 mg weekly dose, he had lost 50 lbs, his A1C was 5.4%, and his BMI dropped to 25.7.

An important part of my job is also avoiding obesogenic medications—drugs like certain sulfonylureas, insulins, and beta-blockers that can cause weight gain.

Chiropractic Integration: How Structural Care Supports Metabolic Therapy

While pharmacological and lifestyle interventions are central, integrative chiropractic care is a foundational element of our holistic approach.

  • Stress Reduction and Nervous System Regulation: Chronic stress is a major driver of metabolic dysfunction. My clinical observations show that patients with central obesity often develop thoracolumbar junction stiffness. Chiropractic adjustments can influence the autonomic nervous system, helping to shift the body from a “fight-or-flight” (sympathetic) state to a “rest-and-digest” (parasympathetic) state. This modulation can lower physiological stress, supporting better glycemic control (Jimenez, n.d.-a).
  • Improving Mobility and Reducing Pain: For patients like Stephen, Victoria, and Banny, joint pain and stiffness can be significant barriers to physical activity. By performing spinal and extremity adjustments, we can improve joint function, reduce pain, and make it easier for patients to engage in regular exercise. This facilitates adherence to activity prescriptions.
  • Optimizing Biomechanics: Correcting thoracolumbar junction dysfunction and sacroiliac joint mechanics can improve gait efficiency and reduce the energy cost of movement, making it easier for patients to increase their daily steps (Jimenez, n.d.-b).
  • Enhancing Sleep Quality: Alleviating neck and upper back tension can support airway mechanics and reduce nocturnal discomfort, which, in my clinical experience, can improve morning glucose stability.

The Chronic Disease Model: Why Treatment Must Be Long-Term

I want to end by reinforcing the most crucial concept: obesity is a chronic, relapsing disease that requires long-term management. The pathology of weight regain is a biological certainty, not a personal failing. When a person with obesity loses weight, the brain initiates a powerful counter-response: metabolism slows down, hunger hormones surge, and satiety hormones decrease. This creates an overwhelming drive to regain weight.

The STEP 1 trial extension starkly illustrates this: when participants stopped taking semaglutide, they began regaining weight, and their blood pressure and A1C levels started to creep back up (Wilding et al., 2022). We must apply the same chronic care model to obesity that we use for hypertension or diabetes. The goal is sustainable, long-term management to control the disease and prevent its devastating complications.

At Injury Medical Clinic, this philosophy guides us. By integrating chiropractic care to restore function, functional medicine to address root causes, and medical oversight from Dr. Cardenas to leverage the best of modern pharmacotherapy, we provide our patients with the comprehensive, long-term support they need to conquer these interconnected diseases and reclaim their health.

SEO Tags: Obesity Treatment, Type 2 Diabetes, Prediabetes Management, Cardiovascular Disease, Integrative Care, Chiropractic, Functional Medicine, Tirzepatide, GLP-1 GIP Agonists, Dr. Alex Jimenez, Dr. Maria Cardenas, El Paso Clinic, Injury Medical Clinic PA, Mission Plaza Injury Medical Clinic, Inflammation, Insulin Resistance, Metabolic Adaptation, Weight Regain, Cardiometabolic Health, Chronic Disease Management, Atherosclerosis, Nitric Oxide, Pharmacotherapy, Menopause and Weight Gain, Continuous Glucose Monitor, Semaglutide

References

PRP Therapy: A Revolutionary Approach For Joint Care

Discover the advantages of PRP therapy for joint care in promoting healing and alleviating joint pain effectively.

Abstract

In this educational post, I share a first-person reflection on the evolving landscape of orthobiologics and integrative musculoskeletal care—where precision medicine, functional rehabilitation, and chiropractic methods come together under robust medical oversight. I summarize key take-home insights from recent collaborative discussions with leading researchers and clinicians, including the roles of platelet-rich plasma (PRP), cellular therapies, photobiomodulation, and outcome-driven standardization. I also describe how our multidisciplinary team at Injury Medical Clinic PA (Mission Plaza Injury Medical Clinic) in El Paso, Texas, integrates chiropractic care with internal medicine, functional medicine, and personal injury services. Under the medical direction of Dr. Maria Guadalupe Cardenas, MD (Board Certified in Internal Medicine; NPI #1164426749; Texas MD License #J2933), we align evidence-based protocols with individualized patient selection, whole-joint strategies, and rigorous data collection. The following sections outline the physiological foundations, practical techniques, and real-world clinical workflows that move patients from pain toward restored function in a structured, collaborative, and patient-centered way.

My Journey in Orthobiologics and Integrative Care

As Dr. Alex Jimenez, DC, APRN, FNP-BC, CFMP, IFMCP, ATN, CCST, I have spent decades treating musculoskeletal injuries, complex pain, and movement disorders through a combination of chiropractic science, functional medicine, and rehabilitation. What has become increasingly clear in recent years is that orthobiologics—therapies that harness the body’s biological resources to heal—are transforming how we approach musculoskeletal injury and degeneration. This is a journey; it requires curiosity, collaboration, and a commitment to both nuance and rigor.

I value small-group, high-clarity, detail-rich conversations where clinicians dissect the “how” and “why” of treatments—PRP preparation variables, cellular therapy indications, dose-response nuances in photobiomodulation, and the biomechanics of joint integration. These exchanges help us push the field forward responsibly. In the last five years, the pace of progress has been remarkable—yet tempered by adherence to data, safety, and ethical boundaries. Our work is a living synthesis of evidence and clinical experience, constantly refined by patient outcomes.

Multidisciplinary Integration: Chiropractic Care With Internal Medicine Oversight

Our practice is a multidisciplinary setup typical of integrative injury clinics. At Injury Medical Clinic PA (Mission Plaza Injury Medical Clinic) in El Paso, Texas, I collaborate closely with Dr. Maria Guadalupe Cardenas, MD, Board Certified in Internal Medicine (NPI #1164426749; Texas MD License #J2933), who serves as Medical Director and Collaborative Physician. With over 40 years of experience as an internist, Dr. Cardenas provides critical medical oversight to ensure safety, precision, and continuity of care in complex cases.

  • Dr. Cardenas’ role:
    • Provides medical direction for patient evaluation, risk stratification, and comorbidity management.
    • Oversees the appropriateness and safety of orthobiologic procedures and adjunctive therapies.
    • Coordinates diagnostics, pharmacotherapy when indicated, and inter-specialty referrals.
  • My role (Chiropractic and Functional Integrator):
    • Performs detailed musculoskeletal examinations and biomechanical analyses.
    • Delivers integrative chiropractic care: spinal and extremity joint adjustments, soft tissue work, neuromuscular re-education, and kinetic chain balancing.
    • Implements functional medicine strategies: inflammation modulation, mitochondrial support, nutrition, sleep optimization, stress tools.
    • Coordinates rehabilitation: graded activity, sensorimotor retraining, strength sequencing, fascial mobility, and return-to-function planning.

This alignment bridges the gap between biologic therapies and functional restoration. By combining medical oversight, chiropractic biomechanics, and functional medicine, we ensure that each patient’s plan is safe, personalized, and outcome-focused.

Evidence-Based Take-Home Insights: The Seven Core Themes

From our latest collaborative dialogues with colleagues in orthobiologics and rehabilitation science, seven take-home insights emerged. Each has strong physiological rationale and clinical utility.

1. PRP and Cellular Therapies: Start Strong and Get It Right

  • Why PRP matters:
    • Platelet-Rich Plasma (PRP) concentrates growth factors (PDGF, TGF-β, VEGF, IGF-1) and bioactive cytokines that modulate inflammation, angiogenesis, cellular migration, and extracellular matrix (ECM) synthesis. When properly prepared, PRP can enhance tenocyte and chondrocyte activity, potentially improving tendon integrity and cartilage homeostasis.
  • Physiology:
    • Platelets release alpha-granule contents upon activation, initiating a controlled cascade that recruits reparative cells, modulates NF-κB signaling, and promotes collagen maturation.
    • Leukocyte concentration influences the inflammatory profile: Leukocyte-poor PRP can be beneficial for intra-articular environments where excessive inflammation risks chondrotoxicity; Leukocyte-rich PRP may be more suitable for tendinopathies where a stronger inflammatory kick-start is appropriate.
  • Clinical tactics:
    • Standardize spin protocols, anticoagulants, and activation steps to reduce variability in growth factor profiles.
    • Tailor PRP composition to tissue target: joint vs tendon vs ligament.
    • Combine PRP with integrative chiropractic joint optimization to create mechanical environments conducive to biologic healing—aligned joint surfaces, normalized load distribution, and restored neuromuscular control.

2. The Future Is Collaborative, Evidence-Based, and Hopeful

  • Research momentum:
    • Modern orthobiologic research uses controlled clinical trials, registry data, cell counting, proteomics, and imaging to clarify mechanisms and outcomes.
    • Collaboration drives innovation—clinicians share protocols, troubleshoot failures, and co-develop standards.
  • Why hope is justified:
    • Incremental evidence is accumulating: improved pain and function for tendinopathy, early osteoarthritis, and select ligament injuries when biologics are integrated with biomechanics and rehabilitation.
  • Integrative chiropractic role:
    • By restoring joint mechanics, we reduce aberrant shear and compressive forces, allowing biologically stimulated tissues to heal under optimal loading conditions.

3. Patient Selection and Precision Medicine: Matching the Right Patient to the Right Therapy

  • Core principle:
    • Patient selection determines success. We assess biological age, metabolic health, systemic inflammation, nutritional status, sleep quality, and psychosocial resilience—all of which influence healing capacity.
  • Precision components:
    • Biologic staging of joint disease (cartilage thickness, synovitis, bone marrow edema).
    • Comorbidity screening (diabetes, obesity, autoimmune disease, smoking) and risk mitigation.
    • Movement profiling: gait, kinetic chain imbalances, scapulothoracic rhythm in shoulder cases, pelvic tilt and lumbar mechanics for spine and hip.
  • Why it matters:
    • Biologics require a responsive milieu. If systemic inflammation, biomechanical overload, or nutrient deficits persist, biologic effects can be muted.
  • Team function:
    • Dr. Cardenas aligns medical management—glucose control, lipid optimization, antihypertensive strategy, and evaluation of medication interactions—with our chiropractic and rehab team, who remodel movement and load.

4. Treat the Whole Joint: The Joint as an Organ

  • Concept:
    • A joint is an integrated organ system of cartilage, subchondral bone, synovium, ligaments, menisci/labrum, capsule, neurosensory feedback, and surrounding musculature and fascia. Isolated treatment misses the interdependence.
  • Physiological rationale:
    • Synovial inflammation alters cartilage metabolism and subchondral perfusion; malalignment drives focal overload and microdamage; motor control deficits create repetitive strain and poor proprioceptive input.
  • Clinical approach:
    • Alignment: Chiropractic adjustments and mobilizations to restore joint kinematics and stacking.
    • Soft tissue: Myofascial release, instrument-assisted techniques, and eccentric loading programs to normalize tension and ECM remodeling.
    • Neuromuscular retraining: Sensorimotor drills for joint position sense and dynamic stabilization.
    • Biologic therapy integration: Intra-articular PRP timed with rehabilitation phases to leverage anabolic windows.

5. Biology Is King: Root-Cause Meets Tissue Microenvironment

  • Meaning:
    • Biological milieu controls outcomes. Micronutrient sufficiency, mitochondrial function, glycation status, redox balance, and endocrine health set the tone for healing capacity.
  • Mechanisms:
    • Mitochondria govern energy supply for ECM synthesis. Excess reactive oxygen species (ROS) impairs collagen cross-linking and chondrocyte function. Insulin resistance increases AGEs (advanced glycation end-products), stiffening collagen and impairing tendon elasticity.
  • Functional medicine integration:
    • Nutritional protocols: omega-3 fatty acids, vitamin D sufficiency, magnesium, collagen peptides, and targeted phytonutrients for inflammation resolution.
    • Sleep and circadian alignment improve hormone balance (GH, cortisol rhythms) and tissue repair.
    • Stress modulation: autonomic balance impacts microvascular perfusion and inflammatory cytokine expression.
  • Chiropractic synergy:
    • Restoring autonomic balance via spinal care, breath mechanics, and mobility reduces sympathetic overdrive and facilitates tissue-level repair.

6. Standardization and Outcomes Data: Protocols That Scale and Improve

  • Why standards:
    • Standardization reduces variability, enhances reproducibility, and speeds learning across clinics.
  • Practical steps:
    • Document PRP preparation details: hematocrit, platelet count, leukocyte fraction, activation method, volume, injection site, and ultrasound guidance.
    • Maintain registries—collect PROMs (pain scales, KOOS/HOOS, DASH), functional metrics (range of motion, strength benchmarks), and imaging outcomes where appropriate.
    • Perform cell counts and, when possible, protein profiling to understand dose-biologic relationships.
  • Data-driven iteration:
    • Aggregated outcomes allow protocol refinement—adjusting PRP concentrations, pairing with specific rehab phases, and identifying subgroups that respond best.
  • Our practice:
    • We contribute to registry efforts and encourage peer clinics to share de-identified data to accelerate the field’s maturity.

7. Photobiomodulation and Optimization: Fine-Tuning the Repair Environment

  • Role of photobiomodulation (PBM):
    • Low-level light therapy can modulate cytochrome c oxidase, enhancing mitochondrial respiration, promoting ATP production, and influencing NO release and microcirculation. This supports the energy demands of tissue repair.
  • Optimization concept:
    • “Sell emac photo optimizations” refers to optimizing cellular photo-responsiveness—adjusting wavelength, dose, and timing to match tissue type and healing stage.
  • Integration:
    • Post-PRP phases may benefit from PBM to reduce pain, modulate inflammation, and support fibroblast and chondrocyte activity.
  • Chiropractic interface:
    • PBM complements neuromuscular re-education—reduced pain facilitates higher-quality motor retraining and better load adherence.

Beyond Medicine: The Power of Chiropractic Care- Video

How Our Team Coordinates Care: From Intake to Restoration

Comprehensive Patient Intake and Stratification

  • Medical screening by Dr. Cardenas:
    • Reviews cardiovascular, endocrine, metabolic, and autoimmune status.
    • Orders labs: CBC, metabolic panel, HbA1c, CRP/ESR, vitamin D, ferritin, lipid profile.
    • Evaluates medication interactions (e.g., NSAIDs around biologic procedures).
  • Musculoskeletal and functional assessment by my team:
    • Posture, gait, joint ROM, segmental motion analysis, palpation, dynamic tests.
    • Imaging when indicated: ultrasound for tendon integrity and guidance; X-ray/MRI for joint structure.

Personalized Plan: Biologics, Chiropractic, and Rehabilitation

  • Biologic layer:
    • PRP or cellular options are selected based on pathology and patient biology.
    • Ultrasound-guided injections to enhance accuracy and safety.
  • Chiropractic layer:
    • Targeted adjustments to restore segmental motion, improve joint mechanics, and relieve compensatory strain.
    • Soft tissue techniques to normalize myofascial dynamics.
  • Functional medicine layer:
    • Nutrition, sleep hygiene, stress resilience, supplementation, and metabolic optimization.
  • Rehabilitation:
    • Phase-based programming:
      • Phase 1: Pain modulation, gentle mobility, PBM.
      • Phase 2: Tissue loading initiation—eccentric and isometric work.
      • Phase 3: Strength integration—closed-chain stability, proprioception.
      • Phase 4: Return-to-sport/work—task-specific drills and load progression.

Outcome Tracking and Iteration

  • Data collection:
    • Patient-reported outcomes, functional measures, and re-imaging when clinically indicated.
  • Iteration:
    • Modify PRP concentration, adjust rehab intensity, refine chiropractic techniques based on biofeedback and progress.
  • Education:
    • We educate patients on the “why” behind each step to increase adherence and empower self-care.

Physiological Underpinnings: Why Each Technique Works

  • PRP and cellular therapies:
    • Growth factor-mediated chemotaxis and ECM synthesis, modulation of inflammatory pathways (e.g., NF-κB), stimulation of resident progenitor cells.
  • Chiropractic adjustments:
    • Normalize joint play and reduce nociceptive input; improve mechanotransduction; restore load distribution to limit microdamage accumulation.
  • Soft tissue work:
    • Break down aberrant cross-linking, encourage realignment of collagen fibers, and improve local perfusion and lymphatic flow.
  • Neuromuscular re-education:
    • Enhance proprioceptive acuity, integrate cortical motor patterns, reduce co-contraction inefficiencies.
  • Functional medicine:
    • Support mitochondrial ATP production, moderate inflammatory tone, correct nutrient deficits essential for collagen synthesis (proline, glycine, vitamin C), and upregulate antioxidant defenses (glutathione system).
  • Photobiomodulation:
    • Upregulates cytochrome c oxidase activity, increases ATP levels, modulates NO-mediated vasodilation, and reduces pain signaling through downstream neuroimmune effects.

Collaboration, Standardization, and the Road Ahead

Our collective message is simple: this is a shared journey. Advancements flourish when clinicians collaborate and standardize, when we respect biology and align mechanics, and when we measure outcomes rigorously. As registry data grows and protocols are refined, we anticipate clearer guidance on dosage, timing, and patient subgroups—transforming hopeful beginnings into reliable, scalable care models.
Our clinic remains committed to:

  • Standardized PRP preparation and documentation.
  • Integration of chiropractic biomechanics with biologic therapies.
  • Functional medicine strategies to sustain healing capacity.
  • Registry participation to contribute to the broader evidence base.
  • Patient-centered education that turns complex science into actionable steps.

Clinical Observations and Practice Philosophy

My clinical observations over years of practice emphasize that sustained recovery emerges when we harmonize biology with biomechanics. Adjustments without biological support may underdeliver in degenerative contexts; biologics without mechanical correction often falter under continued overload. It is the pairing—precise biologic stimulation with optimized joint function and neuromuscular control—that creates a durable healing platform.
You can explore more about my clinical approach and ongoing integrative work:

Summary: A Unified, Patient-Centered Path

I reflected on key themes shaping modern orthobiologic and integrative care:

  • Start strong with well-prepared PRP or cellular therapies, tailored to tissue needs.
  • Embrace collaboration as the engine of progress—share protocols and data.
  • Apply precision medicine—choose the right therapy for the right patient.
  • Treat the joint as an organ—align anatomy, mechanics, and biology.
  • Honor the principle that biology is king—optimize the microenvironment.
  • Standardize protocols and capture outcomes—let data guide growth.
  • Utilize photobiomodulation and related optimizations to support tissue repair.

Together—with medical leadership from Dr. Maria Guadalupe Cardenas and integrative chiropractic strategies—we provide a structured, evidence-informed path for patients recovering from injury and navigating musculoskeletal disease. The future is bright because we are building it on the solid ground of biology, biomechanics, and shared knowledge.

References

SEO tags: orthobiologics, PRP, platelet-rich plasma, integrative chiropractic care, functional medicine, personal injury clinic, musculoskeletal rehabilitation, photobiomodulation, internal medicine oversight, multidisciplinary clinic, El Paso Texas, Injury Medical Clinic PA, Mission Plaza Injury Medical Clinic, patient selection, precision medicine, joint as organ, standardized protocols, outcomes registry, Dr. Alex Jimenez, Dr. Maria Guadalupe Cardenas

Photobiomodulation for Pain Relief and Recovery

Photobiomodulation for Pain Relief and Recovery

Abstract

This educational article explores the profound cellular mechanisms behind Photobiomodulation Therapy (PBMT), often known as laser therapy, and its transformative potential in modern medicine. From a first-person perspective, I will guide you through the scientific journey of how light energy interacts with our cells to promote healing, reduce inflammation, and restore function. We will delve into the latest findings from leading researchers, explaining how PBMT activates mitochondria, modulates cytokine responses, and stimulates tissue regeneration across nerves and muscles. This post will also illuminate the synergistic relationship between PBMT and orthobiologics such as Platelet-Rich Plasma (PRP), demonstrating how combining these therapies can enhance clinical outcomes. Finally, I will explain how we integrate these advanced modalities at our clinic, where a multidisciplinary team approach, featuring integrative chiropractic care alongside medical oversight, provides a comprehensive and evidence-based path to recovery for our patients.

A Personal Journey into the Power of Light

After nearly a decade in this field, I feel like I’ve finally found my people. For years, mentioning the word “laser” in medical circles felt like an uphill battle. I faced skepticism and resistance—metaphorical rotten tomatoes and broken beer bottles for the first five years. Many of you in the regenerative medicine space can likely relate to that struggle. Pushing the boundaries of biologic-based therapies has been a similar journey. That’s why I am so thrilled to have the opportunity to share my experience and the powerful science that has not only vindicated this work but is now revolutionizing how we approach healing.

It all begins with a fundamental biological principle we often overlook: photosynthesis. The sun shines, plants grow, and they sustain life on our planet. We, as a species, have evolved over hundreds of thousands of years under that very sun. Our cells, down to their deepest genetic components, have developed a sensitivity to light.

Think about it this way: from our first days in medical school, we are taught that sunlight is essential for vitamin D synthesis. We accept this without question. Yet a significant gap exists in modern medical education regarding the broader therapeutic applications of light—a field known as Photobiomodulation Therapy (PBMT). This post is my effort to bridge that gap and explain how we can harness light to unlock the body’s innate ability to heal itself.

Our Integrative Approach at Injury Medical Clinic

At our practice, Injury Medical Clinic PA, we believe in a team-based, patient-centered model. My role as a Doctor of Chiropractic (DC) with advanced training as a Nurse Practitioner (APRN) and in Functional Medicine (CFMP, IFMCP) is to focus on the biomechanical, neurological, and metabolic aspects of health. I am privileged to work alongside Dr. Maria Guadalupe Cardenas, MD, a Board-Certified Internist with over 40 years of invaluable experience. Dr. Cardenas serves as our Medical Director and Collaborative Physician, providing essential medical oversight and ensuring our patients receive comprehensive, integrated care.

This multidisciplinary setup allows us to blend the best of different worlds:

  • Chiropractic Care: We address musculoskeletal alignment, nerve function, and biomechanics to restore the body’s structural integrity.
  • Medical Oversight: Dr. Cardenas provides the medical diagnosis, management, and direction necessary for complex cases, especially in personal injury and chronic disease.
  • Functional Medicine: We investigate the root causes of dysfunction, considering genetics, lifestyle, and environmental factors to develop personalized treatment plans.
  • Advanced Therapies: We incorporate cutting-edge modalities like Photobiomodulation (PBMT) and orthobiologics to accelerate healing at the cellular level.

This collaborative environment ensures that when we recommend a therapy like PBMT, it is part of a holistic strategy designed to treat the whole person, not just the symptom.

What is Photobiomodulation? Understanding the Language of Our Cells

Let’s break down the term:

  • Photo: Light
  • Bio: Life
  • Modulation: To affect or change

Photobiomodulation is the process of using light to create a biological change. We know that light is energy, and its fundamental units are photons. Think of photons as the currency of light energy. When these photons penetrate our tissues, they transfer their energy to our cells, initiating a cascade of biological responses.

For the first twenty years of my practice, I was a mechanic, using tools to “fix” conditions. For the last ten, I have become more of a biologist, focused on creating the right environment for the body’s own cells to orchestrate a healing response. Cellular recovery is the goal, and this is where PBMT truly shines.

The Cellular Mechanisms: From Mitochondria to Tissue Repair

Everyone is talking about mitochondrial health and ATP production, but the effects of PBMT go much deeper. Let’s explore the documented cellular reactions that translate into the clinical outcomes we see every day—less pain in the shoulder, knee, or elbow.

1. Mitochondrial Activation and Energy Production

The primary target of PBMT within our cells is an enzyme in the mitochondria called cytochrome C oxidase. This enzyme is a photoacceptor, meaning it is specifically designed to absorb light. When photons of the correct wavelength strike this enzyme, it becomes more active. This supercharges the Krebs cycle, leading to several critical downstream effects:

  • Increased ATP Production: The cell’s energy currency is produced in greater abundance, providing the fuel needed for repair and function.
  • Modulation of Reactive Oxygen Species (ROS): While high levels of ROS cause oxidative stress, a transient, controlled increase acts as a crucial signaling molecule.
  • Release of Nitric Oxide: Light can displace nitric oxide bound to cytochrome c oxidase, allowing oxygen to bind more efficiently and increasing cellular respiration. The released nitric oxide then acts as a vasodilator, improving local blood flow.

This initial spark in the mitochondria triggers a cascade that sends messages all the way to the cell’s nucleus, initiating gene transcription. This is how the cell starts producing the proteins and signaling molecules—cytokines—that direct the healing process.

2. Immune Modulation: Shifting from Inflammation to Repair

When you sustain an injury, your body floods the area with pro-inflammatory cytokines to kickstart the healing process. However, in chronic conditions, this inflammatory state can become “stalled,” preventing true recovery. PBMT helps modulate this immune response.

We can scientifically document that PBMT, using the right wavelength and dose, can:

  • Increase anti-inflammatory cytokines, such as interleukin-10 (IL-10).
  • Reduce pro-inflammatory cytokines, such as interleukin-6 (IL-6).

Essentially, PBMT helps guide the body out of the persistent inflammatory phase and into the reparative, healing phase.

3. Enhancing Blood Flow and Nerve Regeneration

The benefits continue to cascade through the body’s systems:

  • Angiogenesis: PBMT has been shown to stimulate angiogenesis by promoting the production of cytokines, including galectin-1. Improved microcirculation is fundamental for delivering oxygen and nutrients to damaged tissue and removing waste products.
  • Neurogenesis: We can even see improvements at the neuronal level. Studies have demonstrated that PBMT can upregulate proteins like hnRNP K, which are involved in axonal growth and neuronal repair. This is why it’s so effective for nerve-related pain and injury recovery.

4. Accelerating Muscle and Connective Tissue Recovery

  • Muscle Recovery: Using electron microscopy, researchers have confirmed that PBMT improves muscle cell development and increases myoglobin production, thereby enhancing oxygenation and speeding recovery after exertion or injury.
  • Fibroblast Activation: Fibroblasts are the body’s master builders, responsible for producing collagen and forming the structural framework for tissue repair. PBMT provides the energy these cells need to activate and get to work, which is why it pairs so well with orthobiologics that send the initial “go” signal.

By targeting these fundamental cellular processes, PBMT doesn’t just treat conditions like tendonitis or arthritis; it also treats the dysfunctional cells within the pathological tissue. It changes the cellular environment to one that fosters healing. That’s why it has such a broad range of applications for anything that ends in “-itis.”

The Science of Light: Wavelength, Penetration, and the Therapeutic Window

Not all light is created equal. The electromagnetic spectrum ranges from deadly gamma rays with very short wavelengths to harmless radio waves with very long wavelengths. There is a specific “therapeutic window” for PBMT, typically between 600 nanometers (red light) and 1200 nanometers (near-infrared light).

Why is this range so important? It’s all about penetration. To be effective, photons must reach the target tissue. Three primary obstacles stand in their way: skin, blood (hemoglobin), and water. The wavelengths within the therapeutic window are most adept at bypassing these absorbers and penetrating deep into the body, where musculoskeletal injuries reside.

  • Red light (around 600-700 nm) is excellent for superficial tissues. It penetrates only a few millimeters, making it great for skin conditions, but it won’t reach deep muscles or joints.
  • Near-infrared light (around 800-1100 nm) penetrates much deeper, making it the workhorse for orthopedic and musculoskeletal conditions.

At our clinic, we use advanced systems like MLS (Multiwave Locked System) Laser Technology. I am a huge fan of this technology because it synchronizes two different wavelengths—one continuous and one pulsed. The pulsed wavelength, which fires thousands of times per second, allows the tissue to absorb light energy without building up excessive heat. This makes the treatment incredibly safe and effective, allowing for unattended application without the risk of thermal damage.

The Clinical Applications: From Acute Injury to Chronic Pain

In my practice, which includes serving as a team physician for a Division I school, we use PBMT across a spectrum of conditions:

  • Acute Injuries: For our athletes, PBMT is a go-to for sprains, strains, and contusions. It significantly reduces recovery time and gets them back on the field faster.
  • Post-Operative Recovery: Surgery is, in essence, a controlled acute injury. We use PBMT postoperatively to reduce swelling, bruising, and pain, resulting in cleaner incisions and significantly improved patient-reported outcomes.
  • Chronic Inflammatory Conditions: For issues such as a thickened Achilles tendon or degenerative joint disease, where the inflammatory process is stalled, PBMT can reignite the healing cascade.

The evidence is overwhelming. With over 7,000 published studies, PBMT is gaining recognition from major health organizations. The Centers for Disease Control (CDC) mentions “laser photobiomodulation” dozens of times in its revised opioid guidelines as a non-pharmacological option for acute, subacute, and chronic pain. The science is no longer theoretical; it’s a clinical reality.

The Ultimate Synergy: Combining PBMT with Orthobiologics

This is where the magic truly happens. Orthobiologics like Platelet-Rich Plasma (PRP) are rich in growth factors and anti-inflammatory proteins. They are a powerful message sent to the site of injury, instructing the local cells to begin the repair process.

Now, imagine giving those cells the fuel they need to carry out those instructions. That is what PBMT does.

  • Orthobiologics provide the blueprint (the message).
  • PBMT provides the energy (the fuel).

By combining these two therapies, we are creating the optimal environment for cellular activity, healing, and regeneration. People are starting to talk about this synergy. A landmark study in the veterinary world—where patients don’t have secondary gain or placebo effects—provided powerful proof (Ferreira et al., 2021). In this canine study on knee osteoarthritis, dogs were treated with PBMT alone, then PRP alone, and finally a combination of both. The results were clear: the combination therapy produced significantly better outcomes.

The Future is Biology: A Glimpse into Our Research

We are committed to contributing to this growing body of evidence. I’m incredibly proud to share a “proud dad moment.” My son, Zachary, recently completed a study at the Mass General Brigham Enable BioSkills Lab. We took human tenocytes (tendon cells) and applied our laser over them.

The results were astounding: we demonstrated a 20% dose-dependent increase in tenocyte proliferation from PBMT alone.

We are literally proving that we can make tendon cells multiply with light. Our next steps involve qPCR to analyze gene expression and ELISA to measure protein levels. This research helps us move from anecdotal success to hard, reproducible science. The future of orthopedics isn’t just metal and screws; it’s biology. It’s about working with the body, not just on it.

From modulating inflammation to fueling cellular engines, Photobiomodulation Therapy has proven itself to be a cornerstone of modern, integrative care. I’ve witnessed its power firsthand, and I am honored to share this knowledge with you. It has been a pleasure to take you on this journey into the science of light and healing.

References

  • Ferreira, M. P., Tucholski, G. Z., Dória, R. G. S., de Oliveira, B. C., Pimpão, C. T., & De Nardi, A. B. (2021). Intra-articular injections of platelet-rich plasma and photobiomodulation therapy (904 nm) for the treatment of canine osteoarthritis: A double-blinded, randomized clinical trial. Research in Veterinary Science, 139, 270–279. https://doi.org/10.1016/j.rvsc.2021.07.027
  • Jimenez, A. (n.d.). Clinical Observations. Retrieved from https://chiromed.com/ and https://www.linkedin.com/in/dralexjimenez/

Hormone Therapy Facts for Vasomotor Symptoms & Cardiometabolic Risk


Find out how hormone therapy can help manage vasomotor symptoms, cardiometabolic risk, and improve quality of life.

Abstract

I am Dr. Alex Jimenez, DC, APRN, FNP-BC, CFMP, IFMCP, ATN, CCST. In this educational post, I guide you through an easy-to-follow journey through menopause, with a special focus on vasomotor symptoms (VMS), such as hot flashes and night sweats. I explain the physiological underpinnings of the menopausal transition, outline the STRAW +10 staging framework, and discuss the latest research on the hypothalamic KNDy neuron network, which underlies many vasomotor disturbances. I present modern, evidence-based strategies including lifestyle, mind-body therapies, non-hormonal medications, and hormone therapy — with clear reasoning for why we choose transdermal estrogen when possible and how progesterone safeguards the endometrium.
I also introduce our multidisciplinary care model at Injury Medical Clinic PA (also known as Mission Plaza Injury Medical Clinic) in El Paso, Texas, where I work in close collaboration with Dr. Maria Guadalupe Cardenas, MD (Board Certified in Internal Medicine; NPI #1164426749; Texas MD License #J2933). Dr. Cardenas serves as our Medical Director and Collaborative Physician, providing medical oversight that complements my integrative chiropractic and functional medicine approach. Together, we integrate chiropractic care, internal medicine, rehabilitation, personal injury care, and functional medicine to deliver a comprehensive plan for women navigating menopause. Throughout, I include clinical observations drawn from my published insights and professional profile.

Understanding Menopause: Definitions, Timelines, and Systemic Impact

Menopause is a natural, systemic transition characterized by declining ovarian follicular function, culminating in the final menstrual period (FMP) and confirmed after 12 consecutive months without menstruation. This transition is governed by age-related changes in the hypothalamic-pituitary-ovarian (HPO) axis and affects multiple organ systems.
Key points:

  • The median age of menopause in the United States is about 52.5 years.
  • Early menopause occurs before 45, and premature menopause occurs before 40, prompting further medical evaluation.
  • Menopause exerts systemic effects on the skeletal, cardiovascular, genitourinary, and nervous systems, among others.

Why this matters: When estrogen and progesterone decline, it is not just reproductive tissues that change; vascular tone, bone remodeling, thermoregulation, neurotransmission, and metabolic pathways are all influenced by this hormonal shift. Recognizing menopause as a multi-system process keeps our care holistic and coordinated.

The STRAW +10 Staging System: A Clinical Roadmap

The STRAW +10 criteria standardize the stages of reproductive aging and help clinicians and patients contextualize symptoms and lab findings:

  • Stage -5 to -3 (Reproductive years): Regular cycles; FSH in normal range.
  • Stage -2 (Menopausal transition/perimenopause):
    • Menstrual cycles become variable; length can change by 7 days or more.
    • Later in transition, amenorrhea may occur for 60+ days.
    • FSH begins to rise (late transition often shows FSH > 25 IU/L).
    • VMS frequently starts here.
  • Stage +1 to +2 (Postmenopause):
    • Menstruation ceases, and FSH remains elevated.
    • VMS often peaks in early postmenopause (+1) and may persist into late postmenopause (+2).

Why staging helps: Symptom patterns — especially hot flashes — often intensify around the FMP and early postmenopause. Understanding where you are in the STRAW +10 framework helps tailor testing, treatment timing, and expectations.

The Hormonal Symphony: Inhibin, FSH, Estrogens, Progesterone, and Androgens

The menopausal transition reflects a coordinated shift among several hormonal actors:

  • Inhibin B: Declines early. Reduced inhibitory feedback to the pituitary leads to rising FSH.
  • FSH (Follicle-Stimulating Hormone): Rises and fluctuates as the pituitary attempts to stimulate waning ovarian function.
  • Progesterone: Falls with decreasing ovulation frequency, contributing to cycle irregularity and sleep/mood changes.
  • Estrogens:
    • Estradiol (E2): The most potent premenopausal estrogen; declines markedly after menopause.
    • Estrone (E1): Becomes predominant postmenopause, produced in adipose tissue and adrenal pathways; decline is less pronounced than estradiol.
  • Testosterone: Gradually declines with age; typically remains within lower-normal ranges in post-menopausal women.
  • DHEAS: Declines with age but is relatively independent of menopause per se.

Why routine testing is limited: For women over 45, hormone levels fluctuate daily, reducing the clinical utility of single-point testing. Diagnosis remains primarily clinical (history and cycles), though testing can be pursued through shared decision-making when desired, with results interpreted cautiously.

The Broad Symptom Spectrum: VMS, GSM, Cognitive, Metabolic, and Musculoskeletal Changes

Menopause can present across multiple domains:

  • Vasomotor Symptoms (VMS): Hot flashes and night sweats.
  • Genitourinary Syndrome of Menopause (GSM): Vaginal dryness, dyspareunia, urinary urgency, and stress incontinence.
  • Psychological and Cognitive: Mood swings, anxiety, depression, sleep disturbance, brain fog, and memory changes.
  • Metabolic/Cardiovascular: Central weight gain, dyslipidemia, and elevated CVD risk.
  • Musculoskeletal/Dermatological: Arthralgia, decreased bone density, dry skin, brittle nails, thinning hair, and changes in breast fullness.

Clinical observation: Many patients, like “Miss Jenny” — a composite representation of common clinical scenarios — initially present with severe night sweats and only later recognize associated joint pain, mood changes, and urinary symptoms. Bringing these into one coherent picture is often the first empowering step in care.

Why Hot Flashes Occur: Thermoneutral Zone and KNDy Neuron Physiology

A hot flash is a sudden, intense sensation of heat accompanied by flushing and sweating, often followed by chills. Over 80% of women experience VMS before or after the FMP, sometimes lasting an average of 7 years, with notable variability across populations.
Physiology of VMS:

  • The hypothalamus maintains a thermoneutral zone — a range where the body does not need active cooling or warming.
  • Estrogen helps keep this zone wide and stable.
  • With estrogen decline, the thermoneutral zone narrows. Minor increases in core temperature can trigger peripheral vasodilation and diaphoresis — the hallmark hot flash.
  • KNDy neurons (kisspeptin/neurokinin B/dynorphin) in the hypothalamus are central players. Neurokinin B stimulates these neurons; estrogen normally inhibits them. When estrogen falls, unopposed NKB leads to overactive KNDy signaling and hot flashes (Rance, 2017).

Clinical implications:

  • Targeting NK3 receptors offers a non-hormonal path to VMS relief, especially for patients who cannot use estrogen.
  • Severe, prolonged VMS correlates with increased cardiovascular risk, warranting proactive assessment and management (Thurston et al., 2021).

References:

  • Rance, K. N. (2017)
  • Thurston, R. C. et al. (2021)

Aligned & Empowered: Chiropractic Conversations on Women’s Health- Video

Our Multidisciplinary Care Model: Internal Medicine Oversight and Integrative Chiropractic

I practice at Injury Medical Clinic PA — also known as Mission Plaza Injury Medical Clinic — in El Paso, Texas, within a multidisciplinary, integrative model that is common to advanced integrative and injury care clinics.

  • I am Dr. Alex Jimenez, DC, APRN, FNP-BC, CFMP, IFMCP, ATN, CCST, a dual-licensed Doctor of Chiropractic and Family Nurse Practitioner with extensive training in functional medicine. My clinical observations and practice insights are available at my professional sites:
  • Our Medical Director and Collaborative Physician, Dr. Maria Guadalupe Cardenas, MD (NPI #1164426749; Texas MD License #J2933), is Board Certified in Internal Medicine and brings over 40 years of clinical experience. Her medical oversight ensures diagnostic precision, safe medication management, and robust integration with internal medicine best practices.

How this integration works:

  • Medical oversight (Dr. Cardenas): Guides diagnostics, manages comorbidities, supervises hormone therapy (HT) and non-hormonal prescriptions, and ensures evidence-based protocols.
  • Integrative chiropractic and functional medicine (Dr. Jimenez): Addresses neurological regulation, musculoskeletal integrity, stress physiology, nutrition, and biochemical imbalances that influence symptom burden.
  • Rehabilitation and personal injury care: Provides targeted therapy for pain, mobility, and functional restoration — particularly valuable when arthralgia, postural changes, or fall risk emerge during menopause.

This blended care model creates a seamless, patient-centered pathway in which a coordinated team manages complex menopausal presentations under one roof.

Treatment Spectrum: Lifestyle, Mind-Body, Non-Hormonal, and Hormonal Therapies

Menopause is deeply personal; decisions are guided by shared decision-making, clinical history, and patient preference. We build a plan from the least invasive to the most advanced, ensuring safety, efficacy, and alignment with patient goals.
Lifestyle and home management:

  • Dress in layers; maintain a cool sleep environment.
  • Identify triggers: caffeine, alcohol, spicy foods.
  • Hydration and regular exercise (aerobic plus resistance) to support vascular health and mood regulation.

Mind-body therapies:

  • Cognitive Behavioral Therapy (CBT) can reduce the severity (though not always the frequency) of hot flashes and improve sleep and coping skills.
  • Clinical hypnosis may offer non-pharmacologic symptom relief; scalability can be limited by access and cost.

Non-hormonal medications:

  • SSRIs/SNRIs (e.g., paroxetine) can reduce VMS frequency/intensity for patients avoiding hormones.
  • NK3 receptor antagonists directly target KNDy neuron pathways, offering modern, mechanism-based VMS relief.

Why these work:

  • CBT/hypnosis recalibrate cognitive appraisals and autonomic arousal, blunting thermoregulatory triggers.
  • SSRIs/SNRIs modulate serotonergic pathways that influence hypothalamic thermoregulation.
  • NK3RAs precisely address the NKB-KNDy axis, treating VMS at its neuronal source.

Hormone Therapy: Indications, Formulations, and the Case for Transdermal Estrogen

When symptoms are moderate to severe, hormone therapy (HT) is often the most effective strategy. The FDA-approved indications include:

  • Moderate to severe VMS
  • Prevention of bone loss
  • GSM symptoms (prefer local vaginal estrogen when GSM is the sole complaint)
  • Premature or early estrogen deficiency (before age 40)

Why transdermal is often preferred:

  • First-pass hepatic metabolism is avoided. Oral estrogen increases hepatic production of clotting factors, elevating DVT/PE risk; transdermal routes minimize this risk.
  • Stable serum levels reduce peaks/troughs, improving tolerability and symptom control.
  • Lower effective doses achieve clinical benefit without unnecessary hepatic load.

Common transdermal options:

  • Estradiol patches (weekly or biweekly; e.g., generics, Vivelle-Dot, Climara)
  • Estradiol gels/mists (e.g., Divigel, Evamist) — remind patients to let applications dry completely before dressing

Oral therapies:

  • Estrogen-only for women with hysterectomy (e.g., conjugated equine estrogens, plant-derived estradiol). Shared decision-making respects ethical or preference concerns about animal-derived products.
  • Combination estrogen + progestin for women with a uterus:
    • Prevents endometrial hyperplasia/cancer by opposing estrogen-induced endometrial proliferation.
    • Micronized progesterone (Prometrium) is often preferred for tolerability and possibly lower breast cancer risk compared to certain synthetic progestins.

Special formulations:

  • CEE + SERM (bazedoxifene): A combination that protects the uterus (SERM acts as an antagonist there), supports bone health, and addresses VMS without a traditional progestin.
  • Parenteral estradiol (IM estradiol valerate/cypionate): In select, severe cases, provides sustained levels; pharmacokinetics differ (valerate peaks faster; cypionate is smoother).

Clinical guardrails:

  • Initiate HT ideally within 10 years of menopause onset and before age 60 to align with the timing hypothesis favoring cardiovascular safety.
  • For migraines with aura, prefer low-dose transdermal to reduce serum fluctuations that can trigger events.
  • In VTE history or hyperlipidemia, transdermal is safer. Coordinate care with internal medicine or specialist oversight.

References:

  • ACOG Practice Bulletin No. 141 (2014)
  • The NAMS 2022 Position Statement Advisory Panel (2022)
  • Rossouw et al., WHI (2002)
  • Vinogradova et al. (2019)
  • Manson et al. (2013)
  • Collaborative Group on Hormonal Factors in Breast Cancer (2019)
  • Fournier et al. (2008)

Expected Side Effects, Adverse Risks, and Monitoring Protocols

First 3–6 months: set expectations

  • Irregular bleeding/spotting (common early; ensure progesterone compliance)
  • Breast soreness, bloating, headaches
  • Stomach cramps, transient hair changes

Long-term risks to discuss transparently:

  • Stroke: Risk increases with both estrogen-only and combination therapy; lower risk with transdermal versus oral.
  • DVT/PE: Elevated with oral conjugated estrogens; reduced with transdermal.
  • Endometrial cancer: Prevented by daily micronized progesterone in women with a uterus; local vaginal estrogen has minimal systemic exposure.
  • Breast cancer: Risk increases with duration — typically after 3–5 years for combined therapy and ~7 years for estrogen-only; risk profile may be more favorable with micronized progesterone than with synthetic progestins.
  • Gallbladder disease: Slightly increased risk.

Annual monitoring (medical oversight is essential):

  • Review tolerability, efficacy, and side effects; consider dose reduction if stable and symptom-free.
  • Pelvic exam and clinical breast exam.
  • Cervical cancer screening per guidelines; ensure mammograms are up to date.
  • Screen for osteopenia/osteoporosis (DEXA as appropriate).
  • Assess cardiometabolic health: BP, lipids, A1c/glucose, cardiovascular symptoms.
  • Address new comorbidities; coordinate specialist care when indicated.

Internal medicine supervision:

  • Dr. Cardenas ensures HT decisions are made within a comprehensive medical context and that surveillance aligns with best practices in women’s health.

Genitourinary Syndrome of Menopause: Local Estrogen Strategies that Work

GSM symptoms often persist despite systemic therapy. In these cases:

  • Use local vaginal estrogen (cream, ring, tablet) to restore epithelial thickness, lubrication, and pH balance.
  • Apply a small, pea-sized amount internally and carefully over the urethral meatus to target the periurethral estrogen receptors. Clinically, this reduces overactive bladder symptoms and recurrent UTIs, improving quality of life.

Why local therapy excels:

  • Direct tissue exposure with minimal systemic absorption.
  • Supports urogenital mucosa and local immune defense, reducing dysbiosis and infection propensity.

Cardiometabolic and Cognitive Considerations: The Timing Hypothesis and Beyond

Evidence supports the timing hypothesis:

  • Initiating HT before age 60 or within 10 years of menopause improves endothelial function, lipid profiles, and inflammatory markers, reducing CVD risk.
  • Type 2 diabetes risk appears lower with HT, likely via improved insulin sensitivity and glucose metabolism (NAMS, 2022; Boardman et al., 2015).

Neurocognitive benefits:

  • Estrogen’s neuroprotective effects may improve mood stability, sleep architecture, and cognitive clarity, especially during the transition when fluctuations are most disruptive.

References:

  • The NAMS 2022 Position Statement Advisory Panel (2022)
  • Boardman et al. (2015)
  • Mishra et al. (2021)

Integrative Chiropractic Care: Nervous System Regulation, Musculoskeletal Health, and Functional Medicine

My integrative chiropractic approach complements medical management by targeting the neurological, structural, and metabolic dimensions of menopause:
Nervous system regulation:

  • Chiropractic adjustments and neuromuscular re-education reduce nociceptive input, improve autonomic balance, and support hypothalamic regulation. When stress-related signals abate, VMS triggers often lessen, and sleep improves.
  • By optimizing spinal biomechanics, we reduce physical stressors that amplify HPA-axis dysregulation and cortisol volatility.

Musculoskeletal health:

  • Menopause-related arthralgia and stiffness reflect changes in cartilage lubrication, connective tissue elasticity, and inflammatory tone under low-estrogen states.
  • We implement joint-specific adjustments, soft tissue therapies, and corrective exercise programs.
  • Weight-bearing and strength training support bone density and fracture prevention; balance training mitigates the risk of falls.

Functional medicine and nutrition:

  • Personalized plans assess micronutrient status (e.g., Vitamin D, calcium, magnesium, Vitamin K2) and inflammation markers to support bone and vascular health.
  • Anti-inflammatory nutrition and phytoestrogen-rich foods may modestly ease symptoms and reduce cardiometabolic risk.
  • Stress modulation (mindfulness, breath training) lowers sympathetic overdrive, a VMS trigger.
  • Targeted supplementation (e.g., magnesium for sleep/mood, B vitamins for energy/nerve function, and adaptogens) is selected on a case-by-case basis, grounded in evidence and monitored for efficacy (Geller & Studee, 2005).

How we integrate:

  • Under Dr. Cardenas’s medical direction, we align HT or non-hormonal medications with chiropractic and functional strategies, monitoring outcomes and making collaborative adjustments for safety and maximal relief.


References:

  • Geller & Studee (2005)
  • Jimenez (2025a, 2025b)

Shared Decision-Making and Follow-Up: Ethical, Personalized Care

Every treatment plan rests on an honest, individualized conversation:

  • We present a balanced, evidence-based picture of benefits and risks.
  • We respect patient preferences, cultural perspectives, and prior experiences.
  • We clarify the importance of progesterone in women with a uterus.
  • We outline expected early side effects versus warning signs to call the clinic.
  • We revisit the plan as symptoms or comorbidities evolve, avoiding automatic discontinuation at age 60 and opting for reassessment instead.

Clinical example:

  • “Miss Jenny,” exhausted by nightly sweats and daytime fatigue, began transdermal estradiol with micronized progesterone after shared decision-making. At six weeks, she reported sleeping through the night with VMS resolution and improved mood. This kind of transformation is common when therapy is timed well and paired with integrative support.

Practical Takeaways: Building Your Personalized Plan

  • Start with lifestyle: cool room, trigger management, exercise.
  • Consider CBT/hypnosis for severity reduction and coping.
  • Explore non-hormonal pharmacology if estrogen is contraindicated or undesired.
  • If using HT, prefer transdermal estrogen where appropriate; ensure progesterone protection with a uterus.
  • Address GSM with local estrogen; include periurethral application to reduce OAB/UTI.
  • Integrate chiropractic, rehabilitation, and functional medicine for nervous system regulation, pain reduction, bone health, and metabolic support.
  • Monitor annually under internal medicine oversight; adjust dosing and strategies based on outcomes and evolving health.

References

SEO tags: menopause, vasomotor symptoms, hot flashes, night sweats, KNDy neurons, transdermal estrogen, micronized progesterone, genitourinary syndrome of menopause, cognitive behavioral therapy, NK3 receptor antagonists, North American Menopause Society, ACOG guidelines, cardiovascular timing hypothesis, osteoporosis prevention, chiropractic care, functional medicine, integrative women’s health, El Paso Texas, Injury Medical Clinic PA, Mission Plaza Injury Medical Clinic, Dr. Alex Jimenez DC APRN, Dr. Maria Guadalupe Cardenas MD

Post-Accident Pain: Why Symptoms Are Delayed

Post-Accident Pain: Why Symptoms Are Delayed

Post-Accident Pain: Why Symptoms Are Delayed

A minor car accident can feel confusing. You may step out of the vehicle, check for damage, and think, “I feel okay.” But later that night, the next morning, or even a few days later, pain may begin. This is very common after motor vehicle accidents.

Delayed symptoms often appear 24 to 72 hours after a crash. Some symptoms may even show up weeks later. This happens because the body releases adrenaline and endorphins during stressful events. These chemicals can hide pain at first. Once the body calms down, inflammation, muscle tightness, nerve irritation, and joint stiffness can become easier to feel (Centers for Neurosurgery, Spine & Orthopedics, n.d.).

At ChiroMed, the goal is to help patients understand what their body may be telling them after a crash. Even a low-speed accident can affect the neck, back, muscles, joints, discs, and nerves. Early evaluation can help identify injuries before they become long-term problems.

Why You May Feel Fine Right After the Crash

During a motor vehicle accident, the body reacts fast. Your muscles tighten. Your heart rate goes up. Your brain focuses on safety. This stress response can make pain feel smaller than it really is.

Later, when the stress response slows down, symptoms may begin. Inflammation can increase. Muscles may spasm. Joints may stiffen. Nerves may become irritated. This is why someone may feel okay at the scene but wake up the next day with neck pain, headaches, low back pain, or stiffness.

Common delayed symptoms after a minor car accident include:

  • Neck stiffness or pain
  • Back pain or tightness
  • Headaches
  • Shoulder pain
  • Numbness or tingling in the arms or legs
  • Dizziness
  • Fatigue
  • Brain fog
  • Irritability
  • Trouble sleeping
  • Pain that gets worse with movement

Whiplash is one of the most common delayed injuries after a crash. Mayo Clinic explains that whiplash can cause neck pain, stiffness, headaches, dizziness, fatigue, and pain that radiates to the shoulder, arm, or upper back (Mayo Clinic, 2024).

Why Delayed Symptoms Should Not Be Ignored

Pain after a crash is not always just soreness. It can be a sign that the body has been injured. Soft tissues such as muscles, ligaments, tendons, and fascia can be stretched or strained. Spinal joints may lose normal motion. Discs may become irritated. Nerves may become compressed or inflamed.

Some symptoms may also point to a more serious issue. For example, a worsening headache, sudden weakness, confusion, recurrent dizziness, or new numbness should be taken seriously. The CDC notes that worsening headaches, weakness, numbness, poor coordination, repeated vomiting, confusion, or unusual behavior after a head injury can be danger signs that need urgent medical attention (Centers for Disease Control and Prevention, 2025).

Seek immediate medical care if you have:

  • Sudden weakness
  • Severe dizziness
  • Worsening headache
  • Confusion or slurred speech
  • New numbness or loss of coordination
  • Severe abdominal pain
  • Chest pain
  • Pain that becomes sharp, severe, or rapidly worse

These symptoms do not always mean something life-threatening is happening, but they should be checked quickly.

How ChiroMed Looks at Car Accident Recovery

ChiroMed’s approach to accident recovery focuses on the whole injury pattern, not just one painful area. After a crash, the body may create compensation patterns. This means one area becomes tight or overworked because another area is injured or not moving well.

For example, a neck injury may lead to shoulder tension. A low back injury may change the way a person walks. Muscle guarding may cause joint stiffness. Nerve irritation may create tingling or pain that travels into the arms or legs.

An integrative chiropractic care plan may look at:

  • Spinal alignment
  • Joint motion
  • Muscle tension
  • Posture
  • Nerve irritation
  • Range of motion
  • Strength and balance
  • Functional movement
  • Pain patterns after the crash

This type of care can help connect symptoms to the mechanics of the injury.

Chiropractic Care After a Minor Motor Vehicle Accident

Chiropractic care may help restore healthy movement after a crash. The goal is not only to reduce pain. The goal is also to improve how the spine, joints, muscles, and nerves work together.

After a motor vehicle accident, chiropractic care may include:

  • Gentle spinal adjustments
  • Soft tissue therapy
  • Myofascial release
  • Stretching and mobility work
  • Posture correction
  • Decompression when appropriate
  • Corrective exercise
  • Rehabilitation planning

Chiropractic adjustments and soft-tissue care may help reduce joint restrictions, improve mobility, and decrease stress on irritated tissues. This can be especially helpful when the body is guarding after a crash.

The Role of Medical Oversight in an Integrative Injury Clinic

An integrative injury clinic often includes more than one type of provider. This model can be helpful because car accident injuries may involve the spine, muscles, joints, nerves, inflammation, and overall health.

Dr. Maria Guadalupe Cardenas, MD, is described as a board-certified internal medicine physician, Medical Director, and Collaborative Physician for Injury Medical Clinic PA, also known as Mission Plaza Injury Medical Clinic, in El Paso, Texas. Her listed credentials include NPI #1164426749 and Texas MD License #J2933. This type of medical direction supports a multidisciplinary setup where internal medicine oversight works alongside chiropractic and injury care.

Dr. Alexander Jimenez, DC, APRN, FNP-BC, brings a combined focus in chiropractic care, nurse practitioner evaluation, functional medicine, rehabilitation, and personal injury care. His clinical observations often focus on identifying the root cause of pain, documenting injury patterns, and helping patients recover function after car accidents.

Together, this model helps support a more complete recovery plan. Chiropractic care can focus on biomechanics and movement. Medical oversight can help with broader clinical screening, internal medicine concerns, and coordination when referral or advanced evaluation is needed.

Functional Medicine and Recovery After a Crash

Functional medicine looks at how the whole body supports healing. After a car accident, inflammation, sleep problems, stress, nutrition, and metabolic health can all affect recovery.

A functional medicine approach may support:

  • Inflammation control
  • Better sleep
  • Tissue repair
  • Healthy weight support
  • Blood sugar balance
  • Nutrition for healing
  • Energy and recovery

This matters because the body needs the right healing environment. If a person is not sleeping, eating poorly, or dealing with high stress, recovery may take longer.

Regenerative Therapies and Soft Tissue Healing

Some patients may continue to have pain after the early injury phase. In certain cases, regenerative therapies may be discussed. These therapies are designed to support the body’s natural healing response.

Platelet-rich plasma, or PRP, is one example. PRP uses a patient’s own blood, which is processed to concentrate platelets. Platelets contain growth factors that may support tissue repair. The American Academy of Orthopedic Surgeons explains that PRP has been studied for musculoskeletal injuries, although results can vary depending on the condition, preparation, and patient factors (American Academy of Orthopedic Surgeons, n.d.).

A review of PRP in musculoskeletal medicine notes that PRP is used to support healing in certain bone and soft-tissue conditions, but it should be applied carefully and only when clinically indicated (O’Dowd et al., 2022).

Regenerative injections should not be presented as a guaranteed cure. They are one possible tool in a larger care plan. For many patients, the best results come from combining biological support with improved movement, posture, and spinal mechanics.

Why Regenerative Care and Chiropractic Care Can Work Together

Regenerative therapies may help support the healing environment at the cellular level. Chiropractic care and rehabilitation help improve the movement environment around the injured tissue.

This combination matters because injured tissue may stay irritated if the body keeps moving poorly. For example, if a joint is under too much stress, or if a muscle keeps guarding, healing may be slower. Chiropractic adjustments, myofascial release, posture correction, and rehab exercises may reduce abnormal stress on recovering tissues.

A combined plan may include:

  • Regenerative consultation when appropriate
  • Chiropractic adjustments
  • Myofascial therapy
  • Corrective exercise
  • Mobility training
  • Nutrition support
  • Functional medicine guidance
  • Progress tracking

This gives patients a more complete path to recovery.

Why Early Documentation Matters After an Accident

After a crash, documentation is important. A clear medical record can show when symptoms began, what areas were injured, what exam findings were present, and what care was recommended.

This matters for both health and personal injury cases. Delayed symptoms can be confusing if they are not recorded early. A patient may not feel much pain on day one, but symptoms may be stronger by day two or three. A proper evaluation helps connect the injury pattern to the accident timeline.

Good documentation may include:

  • Patient history
  • Accident details
  • Pain location
  • Range of motion findings
  • Neurological findings
  • Functional limitations
  • Imaging recommendations when needed
  • Treatment plan
  • Progress notes

This helps the care team track recovery and adjust treatment when needed.

What Patients Can Do in the First Few Days

The first few days after a crash are important. Do not ignore symptoms. Do not assume pain will always go away on its own. Listen to your body.

Helpful steps include:

  • Get evaluated by a healthcare provider
  • Write down symptoms each day
  • Avoid heavy lifting until cleared
  • Watch for worsening pain or nerve symptoms
  • Stay hydrated
  • Rest, but avoid staying completely inactive too long
  • Follow professional instructions
  • Seek urgent care for red-flag symptoms

A symptom journal can help. Write down when pain started, where it is located, what makes it worse, and whether it spreads into the arms or legs.

Conclusion: Minor Accidents Can Still Cause Real Injuries

Delayed symptoms after a minor motor vehicle accident are common. Pain may appear 24 to 72 hours later because adrenaline and endorphins can hide symptoms at first. Inflammation, muscle guarding, joint stiffness, and nerve irritation may become more noticeable after the body calms down.

ChiroMed’s integrative injury care approach focuses on understanding the full injury pattern. Chiropractic care, medical oversight, functional medicine, rehabilitation, personal injury care, and regenerative options may all play a role when clinically appropriate.

The goal is simple: reduce pain, restore movement, support healing, and help patients return to daily life with better function.

References

American Academy of Orthopaedic Surgeons. (n.d.). Platelet-rich plasma (PRP).

Centers for Disease Control and Prevention. (2025). Symptoms of mild TBI and concussion.

Centers for Neurosurgery, Spine & Orthopedics. (n.d.). Delayed symptoms after a car accident are common.

Dr. Alex Jimenez. (n.d.). El Paso, TX chiropractor Dr. Alex Jimenez DC | Personal injury specialist.

Dr. Alex Jimenez. (n.d.). How PRP composition influences your healing journey.

Dr. Alex Jimenez. (n.d.). Non-surgical process with musculoskeletal care for PRP therapy.

Healthgrades. (n.d.). Dr. Maria Cardenas, MD – Internist in El Paso, TX.

Mayo Clinic. (2024). Whiplash – Symptoms and causes.

Mayo Clinic. (2024). Whiplash – Diagnosis and treatment.

O’Dowd, A., et al. (2022). Update on the use of platelet-rich plasma injections in musculoskeletal medicine.

Solutions Sports & Spine. (n.d.). Delayed-onset pain after a car accident in Portland.

Osteoarthritis Management Approaches for Adipose-Derived Tissues

Delve into the clinical strategy involving adipose-derived tissues and its impact on managing osteoarthritis effectively.

Abstract

In this educational post, I walk you through modern, evidence-based orthobiologic strategies using adipose-derived tissues for osteoarthritis, including pain reduction and the emerging frontier of cartilage restoration. I explain why adipose tissue yields a high yield of regenerative cells, how safe harvesting techniques work, which processing methods are legal and biologically meaningful in the United States, and how micronized adipose tissue modulates inflammation through cytokine balance. I compare adipose-derived preparations with platelet-rich plasma and hyaluronic acid, discuss dose-response concepts for cultured cells under evolving regulations, and highlight clinical insights from my integrative chiropractic practice that blend orthobiologics with precise biomechanical care, neuromuscular re-education, nutrition, and functional medicine. The aim is to help clinicians and patients understand the physiology, the techniques, the outcomes, and how to integrate these therapies safely and effectively.

Why Adipose-Derived Orthobiologics Matter for Osteoarthritis

I have long asked a simple question in musculoskeletal care: why should we consider using adipose tissue—our body fat—as an orthobiologic resource for joint and soft tissue disease? The answer rests on three powerful facts that shape both clinical practice and patient outcomes:
Adipose tissue contains a high proportion of regenerative cells, including mesenchymal stromal/stem cells (MSCs) and components of the supportive stromal vascular fraction. The cell density in adipose tissue is often higher than in bone marrow aspirates, particularly for MSC-like populations (Bianchi et al., 2013; Zuk et al., 2002).
Adipose tissue is non-essential and relatively abundant for most adults, making it a practical autologous source. This improves patient acceptance and procedural logistics.


The regenerative cell profile of adipose tissue is less affected by aging compared with bone marrow. Multiple studies show bone marrow MSCs decline in number and potency with age, whereas adipose-derived stromal cell populations maintain functional characteristics longer (Beane et al., 2014; Minteer et al., 2013).
When we treat osteoarthritis across a broad adult age spectrum, these factors make adipose-derived tissue a compelling option. The rationale is fundamentally physiological: osteoarthritis involves synovial inflammation, catabolic cytokines, failed repair signaling, and biomechanical overload. Adipose-derived preparations can counter inflammatory cascades and provide trophic cues that nudge tissues toward a more pro-anabolic and homeostatic milieu.

The Physiology: How Adipose-Derived Preparations Modulate Inflammation

A core strength of micronized adipose tissue is its ability to alter inflammatory signaling. In vitro models show that when cells are challenged with lipopolysaccharide (LPS)—a bacterial component that drives NF-κB activation and cytokine release—adding micronized adipose tissue fragments can dampen or block the pro-inflammatory cascade. Mechanistically, this involves changes in the interleukin-1 (IL-1) axis:
Adipose-derived fragments are enriched in IL-1 receptor antagonist (IL-1Ra), a naturally occurring protein that binds IL-1 receptors without activating them, thereby preventing IL-1β from driving catabolism, chondrocyte apoptosis, and matrix metalloproteinase activity (Chevalier et al., 2009; Filardo et al., 2022).
By elevating the IL-1Ra: IL-1β ratio, we skew the joint microenvironment toward an anti-inflammatory, pro-anabolic state. This supports matrix maintenance, reduces synovitis, and protects cartilage from degradative enzymes.
Adipose fragments also carry growth factors and extracellular vesicles that influence chondrocyte behavior and synovial macrophage polarization toward M2 phenotypes, further promoting resolution of inflammation (Bianchi et al., 2013; Freitag et al., 2019).
Clinically, the downstream effects often include reduced pain, improved function, and better tolerance to rehabilitative loading. In my practice, this means patients can engage more effectively in integrative chiropractic interventions—precise joint mechanics, soft tissue mobilization, neuromuscular activation, and gait retraining—because the pain and swelling that previously derailed consistency begin to loosen their grip.

Safety and Technique: Harvesting Adipose Tissue with Confidence

Many clinicians—surgeons and non-surgeons alike—initially feel cautious about adipose harvesting. Fortunately, the standard subcutaneous abdominal harvest is highly safe when performed with proper technique and anatomical respect.
Key procedural principles I emphasize:
Tumescence: we infuse tumescent fluid under the skin to create space, provide analgesia, and limit bleeding. After allowing adequate time for tissue equilibration, we use a blunt cannula with tactile feedback. The non-traumatic tip glides within the subcutaneous plane, and because our non-dominant hand rests on the skin, we always know the cannula position and depth.
Anatomy and danger zones:
Avoid the umbilical ring; the tissue can be fibrous and sensitive. Pressing the cannula against the umbilicus risks bruising and patient discomfort.
Be cautious around C-section scars above the pubis; scar tissue can harbor neovessels and increase bleeding risk. Work around—not through—dense scar planes.
Absolute avoidance of the gluteal and buttock regions for basic adipose harvest. The superficial location of the gluteal/pudendal vasculature presents life-threatening risks. This is not a beginner field; multiple severe complications have been reported. Stay anterior and superficial in safer zones.
Love handles (flanks) are generally acceptable, provided you remain in the anterior coronal plane; the more posterior you venture, the more vascular and less predictable the anatomy becomes.
Fascial layers well protect the omentum and peritoneal cavity; driving a blunt cannula into abdominal viscera with standard technique is extremely unlikely. In cadaver and lab training, clinicians learn depth control and tissue feel, substantially reducing risk.
These details are not mere checklists—they are the lived reality of safe orthobiologic practice. We can perform harvests efficiently and comfortably, setting the stage for quality processing and effective clinical outcomes.

Processing Adipose Tissue: What Makes It Orthobiologic

A critical point in modern orthobiologics: raw fat has to be processed before it becomes biologically useful. We need to break down adipose into micronized fragments that retain stromal cells, extracellular matrix, and anti-inflammatory proteins, in a form suitable for deployment into joints or soft tissues.
Legal and biological lines in the United States:
Systems that mechanically mill, filter, or micro-fragment adipose into small clusters are allowed. These methods reduce clump size, remove red blood cells, and yield a heterogeneous but biologically active mix—this is not “cell therapy,” but it contains stem/stromal cells within the fragments (US FDA guidance; Bianchi et al., 2013).
Use of enzymes to digest adipose into stromal vascular fraction (SVF), followed by culture/expansion, is not allowed for routine clinical use. Enzymatic digestion can also injure cells, dampen their responsiveness, and shift them into a more quiescent phenotype in some contexts.
Why mechanical micro-fragmentation works:
Micro-fragmentation preserves essential ECM cues and perivascular niches that keep stromal cells active, responsive, and trophic. Enzymatic methods strip away these native scaffolds.
Filters and bead-based systems lower RBC contamination, which otherwise promotes oxidative stress and cartilage irritation.
Centrifugation-based aperture processing similarly creates small clusters and separates non-productive fractions.
The biological lesson is straightforward: the way we process adipose dictates its regenerative biology. When we honor cellular microenvironments and maintain anti-inflammatory proteins, we get a potent orthobiologic that aligns with both physiology and regulatory frameworks.

Clinical Evidence: Pain Reduction and Functional Gains

Systematic reviews and pooled clinical analyses consistently report significant reductions in pain and functional improvements with micronized adipose interventions for knee osteoarthritis (Everts et al., 2022; Filardo et al., 2022). When we plot results across studies, we see uniform shifts toward pain relief—patients walk farther, sleep better, and tolerate loading with less synovitis.
In direct comparisons:
PRP + hyaluronic acid (HA) is a strong combination in orthobiologics. Yet, several head-to-head evaluations demonstrate that a single dose of micronized adipose tissue can outperform repeated PRP+HA courses at 6 months and sustain gains in activity for up to 12 months (Freitag et al., 2019; Everts et al., 2022).
The reasons are biochemical and cellular. Micronized adipose delivers sustained IL-1Ra, trophic mediators, and stromal cell signals that maintain modulation longer than the relatively transient effects of PRP and HA alone.
This is why my enthusiasm for adipose-derived options has grown. It is not a trendy technology; it is a methodologically grounded therapy with reproducible clinical effects.

Emerging Frontier: Cartilage Restoration with Cultured Cells

Beyond symptom control, the next horizon is disease modification—restoring cartilage thickness and joint integrity. Outside the United States, and now in selected US contexts through regulated trials, there is Level I evidence that cultured adipose-derived cells at defined doses can increase cartilage thickness on MRI and improve functional scores (Jo et al., 2014; Vega et al., 2015; Freitag et al., 2019).
Important clarifications:
This is distinct from micronized adipose used for anti-inflammatory purposes. Cartilage restoration programs typically involve cell culture and dosing regimens (e.g., around 15 million to 50 million cells) that are not part of standard US practice outside of trials or specific state-supported pathways.
Within the US, evolving avenues include FDA-approved clinical trials and specific programs exploring autologous chondrocyte or MSC approaches. For instance, leading centers have piloted methods combining minced autologous cartilage with allogeneic adipose-derived cells under rigorous oversight, reporting promising early outcomes.
Evidence trends suggest autologous cells may perform better than allogeneic sources for long-term tissue integration and immune compatibility, though research continues (Vega et al., 2015; Freitag et al., 2019).
While most American clinics today should focus on micronized adipose for pain and inflammation, we must educate patients about the trajectory of regenerative care: cultured cellular therapies are likely to mature into mainstream options as regulatory clarity and manufacturing standards progress.

Integrative Chiropractic Care: Where Orthobiologics and Biomechanics Meet

As an integrative clinician, my philosophy is simple: biology unlocks capacity, and biomechanics guide recovery. Adipose-derived orthobiologics reduce inflammation and pain, but that is only half the journey. To achieve durable outcomes, we must address mechanical load, alignment, neuromuscular control, and metabolic resilience.
How I integrate adipose-derived therapies in my practice (chiromed.com; LinkedIn/in/dralexjimenez):
Precision Chiropractic Biomechanics:
I employ segmental adjustments and regional mobilizations to re-establish joints’ neutral zone and optimal motion. Reduced nociception after adipose therapy allows patients to tolerate corrective care without flares.
Soft tissue and fascial mobilization targeting periarticular fibrosis improves gliding and load distribution across the joint surface.
Neuromuscular Re-education:
Focused quadriceps-hamstrings co-contraction training stabilizes the knee during stance; hip abductors and external rotators help control valgus/varus moments that accelerate cartilage wear.
Proprioceptive drills—closed-chain and perturbation-based—teach stable gait under variable surfaces, reducing medial compartment stress.
Kinetic Chain and Foot Mechanics:
Foot pronation and tibial internal rotation substantially affect knee alignment. Custom orthotics or foot-core strengthening recalibrate distal mechanics and protect articular cartilage.
Anti-Inflammatory and Functional Medicine:
Dietary protocols that reduce advanced glycation end-products, improve omega-3:omega-6 balance, and support glycemic control lower systemic inflammatory tone that feeds into synovitis and nociception.
Targeted nutrients—such as curcumin, boswellia, vitamin D, and collagen peptides—may support matrix turnover when combined with biologic interventions (Chevalier et al., 2009).
Load Management and Graded Exposure:
Adipose-derived therapy shifts the joint’s biochemistry in our favor, but tissue adaptation still obeys dose-response rules. I structure graded loading with clear progression criteria: swelling thresholds, pain scales, and gait symmetry measures.
From firsthand observation, patients who pair micronized adipose injections with integrative chiropractic programs show faster pain reduction, smoother motion arcs, and greater adherence to rehab—because they can move more and fear less.

Practical Protocols: Reasoning Behind Each Step

When I design a knee osteoarthritis program using adipose-derived tissue, here is how the reasoning unfolds:
Patient Selection:
Indications: persistent pain and synovitis, mechanical symptoms without advanced malalignment, failure of conservative therapies, or desire to delay surgery.
Contraindications: uncontrolled diabetes, significant bleeding disorders, active infection, or poor wound healing risk.
Harvest and Processing:
Choose abdominal or flank sites per safety rules. Employ tumescence and blunt cannulas. Process using FDA-compliant micro-fragmentation and filtration. Aim to reduce RBC contamination and yield small, active clusters.
Injection Targeting:
Intra-articular knee injections under ultrasound or fluoroscopic guidance ensure accurate delivery to the synovial cavity. In selected cases, peri-ligamentous or meniscal capsular areas can be addressed to modulate local inflammation.
Integrative Follow-Through:
Immediate phase: emphasis on swelling control, pain modulation, and gentle range-of-motion. Start low-grade closed-chain work within 3–7 days if pain allows.
Subacute phase: progressive strength, neuromuscular control, and foot-knee-hip chain alignment. Address lifestyle and nutrition to solidify anti-inflammatory gains.
Maintenance: micro-progression with periodic reassessment. Track outcomes using WOMAC, KOOS, or gait metrics; adjust loads and manual care as needed.
Why these steps? Because the biology of adipose fragments buys us a window of neurochemical calm. This window is precious. We use it to re-establish joint stability, correct movement faults, and teach tissues to withstand load without reigniting catabolic signaling.

Building a Stronger Body = Better Life-Video

Comparing Orthobiologic Choices: PRP, HA, and Adipose

Each orthobiologic has its best use-case:
PRP (platelet-rich plasma) excels in treating tendinopathy and early osteoarthritis by boosting growth factor levels and modulating inflammation. Combined with HA, it enhances lubrication and viscoelastic damping in the joint. Yet its effects may be shorter-lived than those of adipose-derived preparations in moderate OA.
Micronized adipose tissue provides more durable anti-inflammatory activity through IL-1Ra and stromal signaling. It performs well in symptomatic OA where synovitis and pain dominate the clinical picture.
Cultured cells (in trials) aim to restore cartilage, which demands precise dosing and strict manufacturing. This is the frontier for structural regeneration.
In practice, I often begin with micronized adipose tissue for patients who need rapid pain reduction and functional gains, while setting expectations about ongoing mechanical corrections and future possibilities for structural therapies under regulated programs.

Outcomes and Expectations: Realistic Timelines

Based on my clinical observations and published data:
Patients typically report improved pain and function within 2–6 weeks post-injection, with peak benefits often around 3–6 months. Activity gains can be sustained for up to 12 months when combined with integrated care (Freitag et al., 2019; Everts et al., 2022).
Weight management, gait correction, and consistent neuromuscular training magnify and maintain the benefit. Those who skip biomechanical work frequently lose gains because load faults reactivate inflammation.
A subset of patients with advanced joint space loss may need staged approaches or surgical referral. Adipose-derived therapy can still provide pain relief and improve prehabilitation, making surgical outcomes better.

Regulatory Notes and Responsible Innovation

In the United States, clinicians must respect clear regulatory guardrails:
Mechanical micro-fragmentation systems and filtration methods that produce small adipose clusters are permitted for autologous use when compliant with minimal manipulation definitions and homologous use criteria.
Enzymatic digestion, expansion, and culture fall outside routine practice and should be pursued only in FDA-sanctioned trials or strictly structured programs.
Always disclose risks and alternatives. Use informed consent with plain language and realistic expectations.
The science is compelling, but patient safety and ethical practice remain paramount.

Clinical Pearls from Dr. Jimenez

From years of integrative practice:
The combination of micronized adipose tissue + integrative chiropractic accelerates recovery by aligning biochemistry and biomechanics. When pain drops, patients can finally correct movement patterns they’ve avoided for months or years.
Protect the harvest: gentle technique and anatomical respect make adipose procurement straightforward and safe. Avoid the buttocks, honor scars, and remain anterior.
Leverage the window: schedule high-value neuromuscular sessions after injection when pain reduction peaks. The motor cortex learns best when nociception is low.
Think systems: osteoarthritis is joint-local, but it is also systemic. Metabolic health, sleep, and stress all influence inflammatory tone. Treat the person, not just the joint.
For more on my clinical approach, see my resources at chiromed.com and my professional notes at linkedin.com/in/dralexjimenez.

Key Takeaways

Adipose tissue provides a high-yield, age-resilient source of regenerative elements for osteoarthritis care.
Micronized adipose reduces inflammation via IL-1Ra enrichment and stabilizes joint biochemistry.
Safe harvest is achievable with tumescent technique and careful anatomical planning—avoid high-risk zones.
US-legal mechanical processing preserves biologically active fragments; enzymatic digestion and culture are not standard care.
Clinical evidence shows consistent pain reduction, often outperforming PRP+HA at mid-term follow-up.
The future includes cultured cellular therapies for cartilage restoration under regulatory oversight.
Integrative chiropractic care multiplies benefits by correcting the kinetic chain, improving neuromuscular control, and supporting metabolic health.

References

SEO tags: adipose-derived tissue, orthobiologics, osteoarthritis, IL-1Ra, micronized adipose, PRP vs HA, mesenchymal stem cells, cartilage restoration, integrative chiropractic, functional medicine, knee pain, joint inflammation, regenerative medicine, Dr. Alexander Jimenez

Integrative Care for Spine, Joint, and Muscle Pain

Integrative Care for Spine, Joint, and Muscle Pain

Abstract

Hello, I’m Dr. Alex Jimenez. Welcome to our educational post where we will explore the intricate world of musculoskeletal injuries and the advanced, evidence-based treatments we use to promote healing and restore function. In this discussion, I will guide you through the latest findings from leading researchers on conditions such as partial-thickness rotator cuff tears, tendinopathies, and osteoarthritis. We’ll delve into the physiological reasoning behind choosing specific orthobiologic treatments, such as Platelet-Rich Plasma (PRP) and Microfragmented Adipose Tissue (MFAT), based on the severity and nature of an injury. I will share my clinical experience and a systematic algorithm I’ve developed to treat knee osteoarthritis that integrates patient-specific factors to optimize outcomes. We will also examine a groundbreaking machine-learning study that is reshaping how we predict patient responses to PRP therapy by highlighting the importance of metabolic markers such as uric acid and lipoprotein(a). Finally, I will explain how our unique multidisciplinary practice integrates my expertise in chiropractic and functional medicine with the invaluable medical oversight of our Medical Director, Dr. Maria Guadalupe Cardenas, MD, to provide comprehensive, patient-centered care.

A New Era of Collaboration in Patient Care

I am thrilled to announce a significant and exciting development at our practice, Injury Medical Clinic PA. We have formalized a collaborative partnership with Dr. Maria Guadalupe Cardenas, MD, a highly respected, board-certified internist with over 40 years of invaluable experience. Dr. Cardenas (NPI #1164426749, Texas MD License #J2933) has joined our team as the Medical Director and Collaborative Physician.

This multidisciplinary model is a cornerstone of modern integrative healthcare. It allows us to merge the distinct and complementary strengths of different medical disciplines under one roof for the patient’s benefit.

  • Dr. Alex Jimenez, DC, APRN, FNP-BC, CFMP, IFMCP, ATN, CCST: My role involves providing advanced chiropractic care, functional medicine diagnostics, rehabilitation protocols, and administering orthobiologic treatments. I focus on the biomechanical and functional aspects of injury and health, aiming to restore proper movement, reduce inflammation, and stimulate the body’s innate healing processes.
  • Dr. Maria Guadalupe Cardenas, MD (Internal Medicine): As our Medical Director, Dr. Cardenas provides essential medical oversight, diagnostic expertise, and a deep understanding of systemic health. Her extensive experience in internal medicine is critical for managing complex patient cases, identifying underlying medical conditions that may affect healing, and ensuring our treatment plans are safe, effective, and holistically sound.

This partnership allows us to offer a truly integrated service. When a patient presents with a personal injury, chronic pain, or a complex musculoskeletal condition, our team collaborates to provide care. I might perform a biomechanical assessment and use diagnostic ultrasound to visualize a tendon tear, while Dr. Cardenas reviews the patient’s overall health, lab work, and medical history to identify any systemic issues, like metabolic syndrome or autoimmune conditions, that could impede recovery. Together, we formulate a comprehensive treatment plan that may include chiropractic adjustments to restore joint alignment, functional medicine interventions to optimize nutrition, and targeted regenerative therapies, all under the proper medical supervision. This ensures our patients receive the most thorough and effective care possible.

Navigating Orthobiologics with Evidence-Based Precision

When I began practicing in the Washington, D.C. area, surrounded by institutions like the National Institutes of Health (NIH), it became immediately clear that every clinical decision had to be supported by robust evidence. My patient base consisted of physicians and researchers who demanded a data-driven approach. This environment challenged me to develop clear, evidence-based protocols for the use of orthobiologics in my orthopedic practice. We meticulously reviewed the scientific literature to identify conditions where these therapies showed the most promise.

Based on this research, we established a cohort of conditions that respond well to regenerative treatments. Here are some of the primary indications we focus on:

  • Shoulder:
    • Low-grade, partial-thickness rotator cuff tears.
    • Mild-to-moderate glenohumeral arthritis. It is crucial here to consider the Walsh classification (e.g., A1, A2, B1) to ensure the glenoid (the “socket”) has not eroded to the point where the humeral head (the “ball”) is unstable.
  • Elbow:
    • Lateral epicondylitis (“Tennis Elbow”).
    • Medial epicondylitis (“Golfer’s Elbow”).
    • Proximal ulnar collateral ligament (UCL) partial tears.
  • Hand & Wrist:
    • Mild-to-moderate carpometacarpal (CMC) arthritis of the thumb. A well-known study from my professor at the Mayo Clinic provided strong evidence for this application.
  • Hip:
    • Femoroacetabular Impingement (FAI) with mild labral tearing (generally grade two or less). The labrum cannot be shredded, and there should not be large pincer or cam deformities.
    • Gluteus medius tendinopathy.
    • Proximal hamstring tendinopathy (mid-portion, focal tears have shown the best response in my experience).
  • Foot & Ankle:
    • Plantar fasciitis.
  • Knee:
    • Mild-to-moderate knee osteoarthritis.
    • Small, degenerative meniscal tears.
    • More recently, some orthopedic surgeons have referred patients for a PRP injection between 0 and 6 weeks after a rotator cuff repair, and emerging studies support this approach to enhance surgical outcomes.

Clinical Application: Visualizing and Treating Tendinopathy

To truly understand how these treatments work, let’s look at a common example: a partial-thickness tear of the common extensor tendon, also known as tennis elbow. Using musculoskeletal ultrasound, I can visualize the injury in real time. I look at the tendon in both long-axis (to see its length) and short-axis (to see its width) views. This allows me to precisely map the dimensions of the tear.

My clinical experience has shown that a key factor for success is ensuring the treatment is delivered throughout the entire tear. It’s not enough to inject into a single spot. I perform a tenotomy, where I use the needle to gently fenestrate, or break up, the unhealthy, degenerative tissue within the tear. This process stimulates a healing response. I then use the orthobiologic fluid (e.g., PRP) to hydrodissect, or separate, the tissue planes, confirming that the healing agents have fully infiltrated the damaged area along its length and width. This meticulous technique ensures the biologic scaffold can reach all the injured fibers. The study by Mishra and Pavelko (2006) on PRP for chronic elbow tendinosis is one of the foundational papers I often share with colleagues to explain the rationale behind this approach.

A Complex Case: Patellar Tendinopathy

Let’s consider a more complex case. A 31-year-old male weightlifter presented with severe knee pain. His ultrasound revealed multiple issues: a large, high-grade partial-thickness tear of the patellar tendon, significant tendinosis (indicated by heterogeneous changes in tissue texture), and a large calcific deposit near the tibial tubercle. Furthermore, his MRI showed a knee effusion (fluid in the joint) and underlying cartilage defects, pointing toward developing osteoarthritis.

This presents a clinical dilemma: what is the primary pain generator? Is it the torn tendon, the arthritic joint, or the calcification? After a thorough discussion with the patient about the risks and benefits of various options and correlating these findings with his physical exam, I determined his primary pain stemmed from the tendon.

Given the significant size of the tear, I chose to treat it with a tenotomy followed by a PRP injection. A study by Jason Dragoo demonstrated that PRP was superior to a dry needling control for patellar tendinopathy, making it my choice for a tear of this magnitude (Dragoo et al., 2014). This case highlights the importance of precise diagnostics and a targeted treatment strategy, even in the face of multiple pathologies.

Differentiating Treatments: PRP vs. Adipose Tissue

The choice of orthobiologic is not one-size-fits-all. It depends on the severity of the injury. For partial-thickness rotator cuff tears, I often see edema (fluid) on MRI and may also identify an interstitial tear (within the substance of the tendon). My approach is often to treat both the bursal-sided and the interstitial components of the tear. Using ultrasound guidance, I can navigate the needle precisely into the tear, which appears as a dark, hypoechoic area.

Here’s my general thought process on selecting the right biologic:

  • Platelet-Rich Plasma (PRP): I consider PRP for low-grade partial-thickness tears (less than 50% of the tendon’s thickness). PRP is rich in growth factors that signal the body’s cells to initiate a healing and anti-inflammatory cascade.
  • Microfragmented Adipose Tissue (MFAT): I consider MFAT for high-grade partial-thickness tears (greater than 50% of the tendon’s thickness). Adipose tissue provides not only signaling molecules but also a natural biological scaffold through its stromal vascular fraction. This scaffold provides a physical matrix for cells to migrate into and begin repairing the larger defect. I also find MFAT particularly helpful for moderate-to-severe arthritis, where its cushioning and structural support can be highly beneficial.

For example, in a patient with a high-grade rotator cuff tear, I would lean toward MFAT. The ultrasound image would show the needle entering the black, torn area, and I would ensure the adipose graft is deployed throughout the defect to provide that essential scaffold for repair. This distinction is critical for managing patient expectations and achieving the best possible clinical outcome.

An Algorithmic Approach to Knee Osteoarthritis

To standardize my approach and ensure consistent, high-quality care, I’ve developed a treatment algorithm for patients with knee osteoarthritis (OA). If you’re a clinician or a patient trying to understand the process, this framework can be very helpful.

  1. Initial Assessment: Systemic Health & Healing Potential
    • The first step is to look beyond the knee. Does the patient have a systemic inflammatory disease (like rheumatoid arthritis), metabolic syndrome, or other conditions known to impair healing?
    • I will often evaluate hormone levels (e.g., thyroid and testosterone) and even consider a microbiome analysis, as gut health is closely linked to systemic inflammation.
  2. Grading the Arthritis & Considering Advanced Biologics
    • Next, I determine the severity of OA using the Kellgren-Lawrence scale (based on MRI or X-ray).
    • For patients with Grade 3 or 4 (moderate-to-severe) arthritis, I am more likely to consider an advanced biologic like Bone Marrow Aspirate Concentrate (BMAC) or MFAT.
    • I also look for subchondral bone marrow edema on the MRI. This indicates stress and inflammation in the bone beneath the cartilage and often correlates with more severe pain. The presence of significant bone edema is another factor that pushes me toward a more robust treatment like MFAT.
  3. PRP for Mild-to-Moderate OA
    • If the patient has mild-to-moderate (Grade 1-2) OA and none of the complicating factors above, PRP is my first-line orthobiologic treatment.
  4. Timeline and Follow-Up
    • I educate patients on the expected timeline. There is often a temporary increase in pain and inflammation for about three days post-injection.
    • The regenerative process begins to take hold between three and six weeks.
    • By 12 weeks, we should have a clear indication of whether the treatment is working. At this point, I reassess their symptoms. If they have experienced a 60% or greater improvement, we continue with supportive care. If not, we adjust the plan, which might involve a second injection or exploring other modalities.

The Future of Prediction: Machine Learning in Regenerative Medicine

This structured approach is powerful, but the field is constantly evolving. A study published in May 2026 has captured my attention and is already changing my practice. Researchers in China used machine learning to predict clinical responses to PRP for knee osteoarthritis (Wang et al., 2026). They analyzed a vast dataset, including patient demographics (height, weight, BMI) and a wide array of lab markers, to identify the most significant predictors of success.

The results were fascinating and somewhat unexpected. While we often focus on the physical characteristics of the joint, the algorithm found that three key biomarkers were most predictive of a high response rate (improving outcomes from an average of 65% to 85%):

  1. Osmotic Pressure (Joint Swelling): This was intuitive. My clinical experience confirms that patients with recurrent, large effusions (swelling) in the joint do not respond as well. The inflammatory fluid likely dilutes the PRP and creates a hostile environment for healing.
  2. Lipoprotein(a) [Lp(a)]: This was a surprise. Lp(a) is a type of cholesterol associated with cardiovascular risk and inflammation. The finding suggests that a patient’s underlying metabolic and cardiovascular health is directly linked to their ability to heal from an orthopedic procedure.
  3. Uric Acid: Another metabolic marker, high uric acid is known to cause gout but is also a general marker of metabolic dysfunction and inflammation.

This study is a paradigm shift. It compels us to think about the patient as a whole system. It’s not just about the knee; it’s about their entire metabolic milieu. Are they systemically inflamed? Do they have underlying metabolic issues that need to be addressed? This research reinforces the principles of functional medicine that I have integrated into my practice for years. Now, I am more routinely checking uric acid and Lp(a) levels in my patients to better predict their response and to guide a more holistic treatment plan that may include dietary changes, supplementation, and lifestyle modifications alongside the injection.

Addressing Complexities: Subchondral Cysts and Mechanical Environment

During our discussions, a colleague raised an excellent question about treating subchondral bone cysts that can appear on MRI scans near rotator cuff tears. These are small, fluid-filled pockets in the bone. The question was whether I should inject directly into these cysts.

While I am very interested in treating the bone-tendon interface, or “enthesis,” directly injecting into a tiny subchondral cyst is technically very challenging and of questionable efficacy. The needle tip is often larger than the cyst itself, making precise targeting difficult.

In my opinion, the more effective approach is to address the root cause: the chronic mechanical stress on the tendon. These tears often occur where the tendon is constantly being pulled and strained. Treating the tendon itself with an orthobiologic helps to stabilize the area and reduce the chronic pulling force on the bone, which may, in turn, allow the subchondral reactive changes to quiet down.

I have also observed that the location of the tear matters. Tears adjacent to the rotator cable, a thick band of fibers near the biceps tendon, seem to have a poorer prognosis. The constant movement of the nearby biceps tendon can displace the PRP or MFAT, preventing it from remaining localized in the tear. In contrast, tears located more posteriorly, away from these highly mobile structures, tend to have a more stable mechanical environment, allowing the biologic to work more effectively. This underscores the importance of understanding not just the pathology but also the intricate biomechanics of the joint.

References

Hypothyroidism: Key Approaches for Management and Diagnosis


Gain insight into effective hypothyroidism diagnosis and management strategies for a healthier, more balanced life.

The Intricacies of Hypothyroidism: An Integrative Approach to Diagnosis and Management

Hello, I’m Dr. Alexander Jimenez. As a healthcare professional with a comprehensive background spanning chiropractic (DC), advanced practice nursing (APRN, FNP-BC), and functional medicine (CFMP, IFMCP), along with certifications in Advanced Toxinology (ATN) and Chiropractic Cranial Spinal Techniques (CCST), I am dedicated to exploring the intricate connections within the human body. My practice is rooted in integrating multiple disciplines to provide a holistic, patient-centered approach to wellness. Today, I want to guide you through a critical topic that affects millions: hypothyroidism. This condition, often characterized by a sluggish thyroid, can manifest in numerous ways, impacting everything from energy levels and mood to metabolic health. My goal is to guide you through the complexities of hypothyroidism, from its core physiology and subtle subclinical cases to more overt presentations, and demonstrate how a holistic, evidence-based approach can lead to optimal patient outcomes.

As we prepared this educational material, I am reminded of the importance of taking a steady, thoughtful pace in both our lives and our approach to health—a concept echoed by World Sauntering Day, which was celebrated a few years back on June 19th. This idea of “sauntering”—moving with mindful intention—perfectly encapsulates the careful, personalized journey we must take when addressing chronic conditions like hypothyroidism.

Abstract: Navigating Hypothyroidism with an Integrative Framework

This educational post provides a comprehensive, integrative perspective on hypothyroidism, one of the most common endocrine disorders seen in clinical practice. We will journey through the fundamental aspects of this complex condition, starting with its core definition, prevalence, and the crucial role of the hypothalamic-pituitary-thyroid (HPT) axis. We will differentiate between primary, secondary, and tertiary hypothyroidism, with a special focus on Hashimoto’s thyroiditis, the leading cause in the United States, while also touching upon the global impact of iodine deficiency. The discussion will cover the full spectrum of diagnosis, from patient history and physical examination to the interpretation of a comprehensive lab panel, including TSH, TPO antibodies, and thyroid hormone levels. We will delve into the nuances of overt versus subclinical hypothyroidism and outline a patient-centered treatment philosophy. A key focus will be on therapeutic options, from standard-of-care levothyroxine (T4) to liothyronine (T3) and desiccated thyroid extract, emphasizing the “low and slow” dosing strategy and proper medication administration. Finally, we will illuminate how integrative chiropractic care, combined with functional medicine principles, complements medical management by addressing the body’s structural and neurological integrity, thereby supporting overall physiological function and well-being.

Understanding Hypothyroidism: The Core Concepts

At its most fundamental level, hypothyroidism is a condition defined by the reduced production of thyroid hormone. Your thyroid gland, a small, butterfly-shaped organ located at the base of your neck, acts as the body’s master metabolic regulator. Its hormones, primarily thyroxine (T4) and triiodothyronine (T3), influence nearly every cell, controlling the speed of your metabolism, body temperature, heart rate, and much more. When hormone production falters, the entire system slows down.

Statistically, while overt (or clinical) hypothyroidism affects a relatively small portion of the population—about 0.1% to 2%—it is significantly more prevalent in women than in men. This gender disparity is a common theme in autoimmune diseases, and as we will see, autoimmunity is the primary driver of hypothyroidism in developed nations. From a functional medicine perspective, this statistic prompts us to ask why women are more susceptible, leading us to investigate the interplay of genetics, hormonal fluctuations (like those in pregnancy and menopause), and environmental triggers.

The HPT Axis: Your Body’s Thyroid Command Center

To truly grasp hypothyroidism, we must first understand the elegant feedback loop that governs thyroid function: the Hypothalamic-Pituitary-Thyroid (HPT) axis. Think of it as a three-part chain of command, or more simply, like a thermostat and a furnace.

  1. The Hypothalamus: Located in the brain, the hypothalamus is the supreme commander. It constantly monitors the levels of thyroid hormone in your bloodstream. When it detects low levels, it releases Thyrotropin-Releasing Hormone (TRH).
  2. The Pituitary Gland: TRH travels a short distance to the pituitary gland, the “master gland” also in the brain. The pituitary acts as the thermostat. In response to TRH, it secretes Thyroid-Stimulating Hormone (TSH) into the bloodstream.
  3. The Thyroid Gland: TSH travels to the thyroid gland—the furnace—and signals it to produce and release T4 and T3. As these hormone levels rise in the blood, the hypothalamus and pituitary detect the increase and reduce their output of TRH and TSH, respectively. This negative feedback loop ensures that hormone levels remain in a stable, healthy range.

When we classify hypothyroidism, we do so based on where this chain of command breaks down.

  • Primary Hypothyroidism: This is by far the most common type. The problem lies directly within the thyroid gland itself. The gland has failed to produce enough hormone despite receiving clear signals (high TSH) from the pituitary. It’s like pressing the accelerator in a car, but the engine is broken.
  • Secondary Hypothyroidism: The issue originates in the pituitary gland. The thyroid gland is healthy and capable of producing hormones, but it isn’t receiving the TSH signal to do so. This can be caused by pituitary surgery, tumors, radiation, or even traumatic brain injury. Both TSH and thyroid hormone levels will be low.
  • Tertiary Hypothyroidism: This is the rarest form, where the problem starts at the very top—the hypothalamus. The hypothalamus is not producing enough TRH, so the pituitary never receives the signal to release TSH, and consequently the thyroid never receives the signal to produce its hormones.

Understanding this axis is crucial because it dictates our diagnostic approach. A simple TSH test tells us a lot, but a comprehensive panel including Free T4, Free T3, and thyroid antibodies gives us a much clearer picture of where the dysfunction is occurring.

Unpacking the Causes of Primary Hypothyroidism

In my clinical experience at El Paso’s injury and chiropractic clinic, I consistently emphasize the importance of obtaining a thorough, comprehensive history from every patient—because the underlying etiology directly informs how we manage and treat the condition.

Hashimoto’s Thyroiditis: The Autoimmune Culprit

In the United States and other countries with sufficient iodine intake, the overwhelming majority of primary hypothyroidism cases are caused by chronic lymphocytic autoimmune thyroiditis, better known as Hashimoto’s disease. This is an autoimmune condition in which the body’s immune system mounts a cell-mediated attack against thyroid tissue, progressively impairing the gland’s ability to produce T3 and T4. Research from leading immunologists like Fasano (2012) has illuminated the “leaky gut” or intestinal permeability model, which provides a framework for understanding how autoimmunity develops. In my practice, I find that addressing gut health, identifying food sensitivities, and managing chronic inflammation are foundational steps in managing Hashimoto’s.

Key clinical features include:

  • More common in women, with prevalence increasing with age.
  • Presence of anti-TPO antibodies (elevated in the majority of cases).
  • Association with other autoimmune diseases, including Addison’s disease, lupus, Sjogren’s syndrome, and rheumatoid arthritis.
  • Strong familial clustering with Hashimoto’s and Graves’ disease.

Iodine Deficiency: A Global Perspective

While Hashimoto’s is dominant in the U.S., on a global scale, iodine deficiency remains the most common cause of hypothyroidism. Iodine is an essential building block for thyroid hormones—T4 has four iodine atoms, and T3 has three. Without adequate iodine, the thyroid cannot synthesize these hormones, leading to hypothyroidism and often a goiter (an enlargement of the thyroid gland).

Other Acquired Causes of Hypothyroidism

  • Excessive Iodine Intake: While deficiency is a problem, so is excess. Consuming very high levels of iodine, sometimes from supplements like kelp or from exposure to medical contrast dyes, can paradoxically shut down thyroid hormone production in a phenomenon known as the Wolff-Chaikoff effect (Leung & Braverman, 2014).
  • Medication-Induced: Certain medications are well-documented disruptors. Lithium, used for bipolar disorder, inhibits hormone release (Bauer et al., 2020), and tyrosine kinase inhibitors used in oncology can also trigger dysfunction (Illouz et al., 2014). A thorough medication reconciliation is essential.
  • Post-Surgical or Post-Ablation: Patients who have undergone radioactive iodine ablation for Graves’ disease or have had a partial or total thyroidectomy will develop hypothyroidism. It is also important to think beyond direct thyroid procedures. Surgery or radiation therapy to the neck or chest region for other cancers can damage the gland.
  • Post-ICU Illness: Patients recovering from a severe medical illness, sometimes called “sick euthyroid syndrome”, may show temporary thyroid abnormalities. This typically resolves without intervention and requires careful monitoring rather than immediate treatment.
  • Congenital Hypothyroidism: A range of genetic and developmental disorders can impair thyroid function from birth. These are typically identified through newborn screening programs.

“Cracking the Low Thyroid Code: A Comprehensive Assessment Guide”-Video

The Pituitary and Hypothalamic Connection: Beyond the Thyroid

Sometimes, the problem isn’t in the thyroid itself. One of the most clinically underrecognized causes I have encountered in my practice involves post-concussive pituitary injury. The pituitary gland sits on a delicate stalk. During a significant head impact, the mechanical force can disrupt its function. I evaluated a law enforcement officer who, two years after a closed head injury from a high-speed pursuit, developed pituitary dysfunction directly attributable to the trauma. This case underscores the importance of longitudinal follow-up for patients with a history of head trauma or repeated concussions, as delayed-onset hypopituitarism is well-documented (Kokshoorn et al., 2011).

Diagnosing Hypothyroidism: History, Labs, and Clinical Judgment

A thorough history remains the cornerstone of evaluation. Key areas to explore include radiation exposure, neck surgery, new medications, family history of thyroid disease, and dietary changes, particularly iodine-rich supplements.

Key Physical Examination Findings

A systematic thyroid exam involves inspection, palpation (from both the anterior and posterior aspects, with the patient swallowing), and auscultation. In my practice at chiromed.com, this comprehensive approach is standard. Physical signs of hypothyroidism can include:

  • Bradycardia (slowed heart rate)
  • Delayed deep tendon reflex relaxation (a hallmark sign)
  • Periorbital puffiness and myxedematous facial features
  • Thickened, dry skin, coarse hair, and alopecia (hair loss)
  • Diastolic hypertension
  • Enlarged tongue and hoarseness in more advanced cases

Interpreting the Thyroid Panel and Imaging

The core laboratory tests provide a window into the HPT axis.

TestClinical Significance
TSHPrimary screening test; reference range 0.4–4.5 mIU/L
Free T4Evaluates circulating unbound thyroxine
Free T3Active hormone; assesses peripheral conversion
Anti-TPO antibodiesElevated in 85–90% of Hashimoto’s cases
Antithyroglobulin antibodiesMay be elevated in autoimmune thyroid disease
Hypothyroidism can also cause systemic lab changes, including anemia, hyperlipidemia (elevated cholesterol), hyponatremia (low sodium), and elevated creatine kinase (CK). 

Thyroid ultrasound is the imaging modality of choice. In Hashimoto’s, the gland is often diffusely enlarged (goiter) with a heterogeneous echotexture and may show hypoechoic micronodules.

The Challenge of Subclinical Hypothyroidism

One of the more perplexing areas is subclinical hypothyroidism. This is the most common thyroid function abnormality, characterized by an elevated TSH (typically 5-10 mIU/L) with a normal free T4. The decision to treat is not based on labs alone. We must consider the patient’s symptom burden, cardiovascular risk factors (as subclinical hypothyroidism is associated with elevated LDL cholesterol), and the presence of TPO antibodies, which suggest likely progression to overt disease (Rodondi et al., 2010).

It is also critical to distinguish between “Wilson’s temperature syndrome,” a diagnosis not recognized by the American Thyroid Association, and Wilson’s disease, a serious inherited disorder of copper metabolism. These are entirely distinct clinical entities.

The Goals and Strategies of Hypothyroidism Treatment

When a patient is diagnosed with hypothyroidism, our treatment goals are multifaceted:

  • Symptom Resolution: Alleviating fatigue, weight gain, brain fog, and depression.
  • Normalization of Biomarkers: Normalizing serum TSH and improving T4 and T3 concentrations.
  • Avoiding Overtreatment: Preventing iatrogenic thyrotoxicosis (overactive thyroid function from medication), which is especially dangerous for older patients.

The Thyroid-Cholesterol Connection: Treat the Thyroid First

A crucial and often overlooked consequence of hypothyroidism is its impact on lipid metabolism. Hypothyroidism is a common cause of secondary dyslipidemia, leading to elevated triglycerides and Lipoprotein(a) or Lp(a), a potent cardiovascular risk factor. A key principle I’ve learned from my collaborative work in cardiometabolic health is: treat the thyroid first. Before aggressively treating cholesterol, we must optimize thyroid function. Correcting hypothyroidism often leads to a spontaneous improvement in cholesterol levels, creating a stable metabolic foundation.

First-Line Treatment: The Role of Levothyroxine (T4)

The cornerstone of treatment, as recommended by the American Thyroid Association (ATA), is synthetic levothyroxine (T4) (Jonklaas et al., 2014). T4 has a long half-life of five to seven days, providing stable blood levels. The body then naturally converts this storage hormone into the active T3 hormone as needed. For consistency, the ATA has expressed a preference for patients to remain on a specific brand-name product (e.g., Synthroid®, Levoxyl®) due to the narrow therapeutic index of thyroid hormone.

Exploring Other Therapeutic Options: T3 and Desiccated Thyroid

While T4 monotherapy is the standard, it’s not a one-size-fits-all solution.

  • Liothyronine (T3) Therapy: Synthetic T3 is the active hormone. It has a short half-life and is more potent, making dosing challenging. It is sometimes added to a T4 regimen (combination therapy) for patients who may have issues converting T4 to T3.
  • Desiccated Thyroid Extract (DTE): Derived from pig or cow thyroid glands (e.g., Armour® Thyroid), DTE contains a combination of T4, T3, and other compounds. While not a first-line therapy, it is a viable option for patients who do not respond well to T4 alone.

The Art of Dosing: “Go Low and Slow”

The most important principle in initiating and adjusting medication is to “go low and slow.” The body needs time to acclimatize to the increased metabolic rate. We typically use a weight-based calculation of 1.6-1.8 mcg per kilogram of body weight to estimate the final dose, but we never start at this level. We begin with a low dose (e.g., 25-50 mcg), wait six to eight weeks for levels to stabilize, and then recheck the TSH. It is paramount to treat the patient, not the paper. If a patient’sTSH is “normal” but they feel unwell, we must investigate further.

Proper Medication Administration: The Key to Success

The effectiveness of thyroid medication depends heavily on how it’s taken. The golden rules are:

  1. Take it on an empty stomach first thing in the morning.
  2. Take it with a full glass of water only.
  3. Wait 45-60 minutes before eating or drinking anything else (including coffee).
  4. Take it separately from other medications and supplements, especially iron and calcium, by at least four hours.

Special Considerations: Amiodarone and Adrenal Insufficiency

  • Amiodarone, an antiarrhythmic drug, is notorious for causing thyroid problems due to its high iodine content and direct toxicity. Patients on this drug require very close monitoring.
  • It is critical to be aware of potential adrenal insufficiency (Addison’s disease). Starting thyroid hormone in a patient with undiagnosed Addison’s can precipitate a life-threatening adrenal crisis.

Clinical Case Studies: An Integrative Approach in Action

Case Study 1: Sally, The Young Graduate Student with Hashimoto’s

Sally, a 24-year-old graduate student, presented with fatigue, weight gain, and depression. Her mother had Hashimoto’s. Her labs showed a TSH of 6.0, normal T4, and TPO antibodies of 1,100. Her thyroid ultrasound was consistent with autoimmune thyroiditis. She was diagnosed with subclinical hypothyroidism secondary to Hashimoto’s disease.

Instead of starting a high dose, we adhered to the “go low and slow” principle and began with just 25 micrograms of levothyroxine daily. At her six-week follow-up, she felt remarkably better, and her TSH had normalized to 2.5. Her integrative plan also included an anti-inflammatory, gluten-free diet and chiropractic care to manage stress and support neurological function.

Case Study 2: Jane, Unraveling Treatment Complexity

Jane, a 52-year-old postmenopausal woman, presented with fatigue and weight gain despite being on 112 mcg of levothyroxine. Her TSH was elevated at 12. Her history was significant for breast cancer treated with chest radiation, and her thyroid ultrasound showed an atrophic (shrunken) gland. While a dose increase to 125 mcg was indicated, the more important question was why her TSH suddenly increased. After a thorough investigation into medication adherence, formulation changes, and potential GI absorption issues, we increased her dose. Her TSH normalized, and her symptoms improved, underscoring the importance of active, investigative management.

The Role of Integrative Chiropractic Care in Thyroid Health

You might wonder, “How does chiropractic care fit into managing a hormonal condition?” The connection lies in the intricate relationship among the nervous, endocrine, and musculoskeletal systems.

An integrative chiropractic approach goes beyond simple spinal adjustments. We focus on restoring optimal function to the entire body.

  • Neuro-Endocrine Connection: The HPT axis is regulated by the central nervous system. Chronic stress—processed by the nervous system—can disrupt hypothalamic and pituitary function. Misalignments in the spine, particularly in the cervical (neck) region (vertebral subluxations), can create neurological interference. Gentle, specific chiropractic adjustments can help reduce this interference and promote better balance in the autonomic nervous system.
  • Reducing Systemic Inflammation: Inflammation is a key driver of Hashimoto’s. Structural imbalances contribute to chronic physical stress and low-grade systemic inflammation. By correcting spinal alignment and improving biomechanics, chiropractic care can help modulate the inflammatory response (Alcantara & Alcantara, 2012).
  • Holistic Patient Management: As a practitioner with dual certifications, I integrate chiropractic adjustments with nutritional counseling, stress management, and targeted supplementation. For instance, we may identify a need for selenium and zinc, which are crucial for T4-to-T3 conversion, or recommend an anti-inflammatory diet. This comprehensive strategy, which we employ at our El Paso clinic, addresses root causes rather than just managing symptoms. In my clinical experience, patients who incorporate integrative chiropractic care often report improved energy, reduced pain, and a greater sense of well-being.

Conclusion: A Holistic Framework for Thyroid Health

Hypothyroidism is a complex, multifactorial condition that demands clinical precision, comprehensive evaluation, and an integrative treatment perspective. From the foundational physiology of the HPT axis to the nuanced presentations of Hashimoto’s thyroiditis, subclinical hypothyroidism, and post-concussive pituitary dysfunction, every patient requires an individualized approach. By combining thorough history-taking, targeted laboratory evaluation, and integrative chiropractic care, clinicians can deliver outcomes that go far beyond simply normalizing a TSH value—restoring genuine physiological balance and patient well-being.

References

SEO Tags: Hypothyroidism, Dr. Alexander Jimenez, Integrative Chiropractic Care, Functional Medicine, Hashimoto’s Thyroiditis, Thyroid Health, HPT Axis, Primary Hypothyroidism, TSH, Thyroid Hormones, Autoimmune Disease, Chiropractic Adjustment, Systemic Inflammation, Holistic Health, El Paso TX, Functional Medicine Practitioner, hypothyroidism causes, subclinical hypothyroidism, thyroid stimulating hormone, TPO antibodies, secondary hypothyroidism, pituitary dysfunction concussion, thyroid examination technique, thyroid ultrasound findings, hypothyroidism diagnosis, anti-TPO antibodies Hashimoto’s, congenital hypothyroidism, Hypothyroidism Treatment, Levothyroxine, T4 Therapy, Liothyronine, T3 Therapy, Desiccated Thyroid Extract, Thyroid and Cholesterol, Amiodarone Thyroid Dysfunction, Adrenal Insufficiency, Low and Slow Dosing, Cardiometabolic Disease